Sign in
  • S&P 500 7,659.44 −1.09%
  • Dow Jones 52,002.41 −0.34%
  • Nasdaq 26,713.03 +0.08%
  • VIX 19.99 +21.45%
  • 10-year Treasury 5.09% −0.01
  • Dollar index 121.40 −0.14%
  • WTI crude $101.91 +1.04%

Biotech and pharma

2,497 drugmakers and biotech companies: what they’re worth, how long their cash lasts, which trials are due to read out and what the FDA has approved. From SEC filings, ClinicalTrials.gov, Drugs@FDA, FINRA and our market snapshot; prices as of Oct 19, 2026, balance sheets through Aug 31, 2026.

Market snapshot

Prices as of Oct 19, 2026. 920 of the 2,497 companies here have a listed share price; 828 have a market value that passes our checks against SEC share counts and trading volume. Best and worst lists count companies worth $300 million or more.

Listed companies
920
Combined market value
$6.9T
Past month, weighted by value
+1.8%
Past year, weighted by value
+42.3%

Largest by market value

  1. Eli Lilly and Company$1.2TLLY · past year +55.9%
  2. Johnson & Johnson$612.9BJNJ · past year +31.6%
  3. AbbVie$502.0BABBV · past year +23.8%
  4. Merck & Co.$355.1BMRK · past year +69.8%
  5. Novartis$292.1BNVS · past year +14.5%
  6. AstraZeneca$261.6BAZN · past year −2.5%
  7. Amgen$231.3BAMGN · past year +43.2%
  8. Gilead Sciences$191.7BGILD · past year +25.9%
  9. Abbott Laboratories$180.8BABT · past year −19.2%
  10. Novo$173.2BNVO · past year −29.1%
  11. Pfizer$168.0BPFE · past year +20.3%
  12. Vertex Pharmaceuticals$127.2BVRTX · past year +20.4%
  13. Bristol-Myers Squibb$120.9BBMY · past year +35.6%
  14. GSK$100.3BGSK · past year +12.9%
  15. Sanofi$98.4BSNY · past year −21.6%

Best past month

  1. Kodiak Sciences Inc.+183.1%KOD · $5.8B
  2. Greenland Mines Ltd+96.1%GRML · $888.0M
  3. Silence Therapeutics+60.5%SLN · $2.8B
  4. Pacira BioSciences, Inc.+47.3%PCRX · $1.4B
  5. Moderna+47.1%MRNA · $90.5B
  6. North China Pharmaceutical Group Corp+38.2%600812.SS · $1.4B
  7. Iovance Biotherapeutics+35.8%IOVA · $6.3B
  8. Maze Therapeutics, Inc.+34.8%MAZE · $1.7B
  9. Xeris Biopharma Holdings, Inc.+34.6%XERS · $2.0B
  10. Ginkgo Bioworks+29.3%DNA · $649.2M

Worst past month

  1. Impact Biomedical INC.−60.5%IBO · $318.1M
  2. Chemomab Therapeutics Ltd.−54.4%CMMB · $684.7M
  3. uniQure N.V.−49.2%QURE · $1.4B
  4. Liquidia Corporation−48.7%LQDA · $3.1B
  5. BlossomHill Therapeutics, Inc.−47.1%BLSM · $432.9M
  6. Nektar Therapeutics−45.7%NKTR · $1.2B
  7. Faeth Therapeutics, Inc.−43.4%FTH · $504.3M
  8. Apnimed, Inc.−40.6%APMD · $716.9M
  9. Scribe Therapeutics, Inc.−40.5%SCTX · $371.5M
  10. Parabilis Medicines, Inc.−39.2%PBLS · $3.1B

Best past year

  1. GT Biopharma, Inc.+887.7%GTBP · $307.9M
  2. Moderna+771.5%MRNA · $90.5B
  3. Adlai Nortye Group Ltd.+585.1%ANL · $740.6M
  4. Kodiak Sciences Inc.+556.7%KOD · $5.8B
  5. Iovance Biotherapeutics+538.5%IOVA · $6.3B
  6. Erasca, Inc.+458.7%ERAS · $4.7B
  7. Climb Bio, Inc.+408.8%CLYM · $564.0M
  8. Twist Bioscience+399.6%TWST · $8.8B
  9. Galena Biopharma+396.6%SLS · $2.1B
  10. MBX Biosciences, Inc.+297.2%MBX · $2.5B

Worst past year

  1. Gossamer Bio, Inc.−95.1%GOSS · $4.2B
  2. SL Science Holding Ltd−85.0%SLBT · $779.5M
  3. Greenland Mines Ltd−81.4%GRML · $888.0M
  4. Tilray−80.5%TLRY · $449.3M
  5. KOLON Tissuegene−67.2%950160.KQ · $1.0B
  6. Oculis Holding AG−65.9%OCS · $482.2M
  7. Chemomab Therapeutics Ltd.−64.2%CMMB · $684.7M
  8. Evotec−63.5%EVO · $552.6M
  9. uniQure N.V.−61.4%QURE · $1.4B
  10. Impact Biomedical INC.−60.9%IBO · $318.1M

Prices and market values: our daily market snapshot of public market data (market value is the share count in the company’s latest SEC filing times the last price, or the exchange’s own figure for listings outside the U.S.). Prices are for reference only.

Cash runway

How long each money-losing company’s cash would last at its current rate of spending, from its SEC filings.

Formula. Months of runway = cash ÷ (cash used in operations over a year ÷ 12), for companies whose operating cash flow is negative.

Spending. Cash used in operations over the latest fiscal year (10-K). Where the first-quarter 10-Q after that year is on file, we roll it forward a quarter: fiscal year + this year’s first quarter − last year’s first quarter.

Cash. Cash and cash equivalents on the latest balance sheet. Most biotechs also hold short-term investments (Treasury bills, commercial paper) that the filings report separately and we don’t yet extract, so cash alone understates what many have. Current assets (cash, investments, receivables, inventory, prepaid costs) is an upper bound, so we show both and flag a company only when even its current assets cover less than 12 months.

Runway is measured from the balance-sheet date, not from today, and assumes spending stays flat. Companies raise money, cut programs and sign partnerships; this is a starting point, not a forecast.

Listed companies burning cash
561
Median runway on cash
8.4 months
Median runway on current assets
21.6 months
Under 12 months on current assets
165

Latest balance sheet on file: Aug 31, 2026. Companies whose cash flow from operations is positive are left out.

Under 12 months of runway, even counting all current assets

The 40 largest by market value of 165. The full list is in the table of every company below (sort by runway).

CompanyMarket valueCashCurrent assetsCash used in operations, a yearRunway on cashRunway on current assets
Kodiak Sciences Inc.KOD$5.8B$125.9MJun 30, 2026$131.4M$146.9M12 months to Mar 31, 202610.3 months10.7 months
Gossamer Bio, Inc.GOSS$4.2B$41.1MJun 30, 2026$72.7M$170.3M12 months to Mar 31, 20262.9 months5.1 months
Biohaven PharmaceuticalsBHVN$1.7B$238.0MJun 30, 2026$296.6M$594.2M12 months to Mar 31, 20264.8 months6.0 months
Replimune Group, Inc.REPL$1.0B$185.4MJun 30, 2026$200.8M$279.1M12 months to Jun 30, 20268.0 months8.6 months
Prime Medicine, Inc.PRME$692.9M$47.5MJun 30, 2026$96.8M$156.4M12 months to Mar 31, 20263.6 months7.4 months
CytoDyn Inc.CYDY$368.6M$16.4MAug 31, 2026$19.0M$22.5M12 months to Aug 31, 20268.7 months10.1 months
Galectin Therapeutics IncGALT$356.5M$13.3MJun 30, 2026$14.7M$20.1M12 months to Mar 31, 20267.9 months8.8 months
Impact Biomedical INC.IBO$318.1M$20.0KMar 31, 2026$377.0K$1.7M12 months to Mar 31, 20260.1 months2.7 months
GT Biopharma, Inc.GTBP$307.9M$5.0MJun 30, 2026$5.8M$13.2M12 months to Mar 31, 20264.5 months5.3 months
Quoin Pharmaceuticals Ltd.QNRX$284.7M$3.8MJun 30, 2026$11.6M$15.8M12 months to Mar 31, 20262.9 months8.8 months
AgenusAGEN$278.5M$18.7MJun 30, 2026$78.8M$87.5M12 months to Mar 31, 20262.6 months10.8 months
OneMedNet CorpONMD$273.3M$358.0KJun 30, 2026$1.3M$7.2M12 months to Mar 31, 20260.6 months2.2 months
Northwest BiotherapeuticsNWBO$264.4M$595.0KJun 30, 2026$2.6M$47.9M12 months to Mar 31, 20260.1 months0.6 months
Greenwich LifeSciences, Inc.GLSI$220.8M$8.9MJun 30, 2026$8.9M$12.8M12 months to Mar 31, 20268.3 months8.3 months
Medicus Pharma Ltd.MDCX$170.6M$15.2MJun 30, 2026$17.0M$27.8M12 months to Mar 31, 20266.5 months7.3 months
Korsana Biosciences, Inc.KRSA$152.2M$1.4MJun 30, 2026$1.5M$3.5M12 months to Mar 31, 20264.7 months5.2 months
Coherus BioSciences (United States)CHRS$151.7M$82.9MJun 30, 2026$133.8M$170.6M12 months to Mar 31, 20265.8 months9.4 months
Curanex Pharmaceuticals IncCURX$150.6M$2.9MJun 30, 2026$4.8M$11.3M12 months to Mar 31, 20263.1 months5.1 months
Pyxis Oncology, Inc.PYXS$146.0M$18.9MJun 30, 2026$36.7M$67.0M12 months to Mar 31, 20263.4 months6.6 months
Voyager Therapeutics (United States)VYGR$126.6M$35.8MJun 30, 2026$125.2M$128.0M12 months to Mar 31, 20263.4 months11.7 months
Outlook Therapeutics, Inc.OTLK$123.7M$11.2MJun 30, 2026$23.2M$55.8M12 months to Dec 31, 20252.4 months5.0 months
Semnur Pharmaceuticals, Inc.SMNR$119.7M$39.0KJun 30, 2026$1.2M$8.1M12 months to Mar 31, 20260.1 months1.8 months
Scienture Holdings, Inc.SCNX$119.1M$8.2MJun 30, 2026$9.2M$13.3M12 months to Mar 31, 20267.4 months8.3 months
TuHURA Biosciences, Inc./NVHURA$112.5M$996.0KJun 30, 2026$1.7M$27.3M12 months to Mar 31, 20260.4 months0.7 months
Humacyte, Inc.HUMA$112.3M$79.9MJun 30, 2026$92.8M$101.5M12 months to Mar 31, 20269.4 months11.0 months
GENELUX CorpGNLX$111.5M$9.2MJun 30, 2026$19.1M$25.9M12 months to Mar 31, 20264.3 months8.9 months
Inovio PharmaceuticalsINO$103.4M$31.5MJun 30, 2026$39.9M$83.3M12 months to Mar 31, 20264.5 months5.7 months
Atara Biotherapeutics, Inc.ATRA$92.7M$3.2MJun 30, 2026$13.5M$25.9M12 months to Mar 31, 20261.5 months6.3 months
Insight Molecular Diagnostics Inc.IMDX$92.6M$17.8MJun 30, 2026$20.5M$24.0M12 months to Mar 31, 20268.9 months10.3 months
Neumora Therapeutics, Inc.NMRA$88.9M$116.8MJun 30, 2026$124.9M$193.4M12 months to Mar 31, 20267.2 months7.7 months
Neonc Technologies Holdings, INC.NTHI$72.9M$2.0MJun 30, 2026$4.2M$21.7M12 months to Mar 31, 20261.1 months2.3 months
Cardiff Oncology, Inc.CRDF$70.0M$9.2MJun 30, 2026$35.6M$37.4M12 months to Mar 31, 20262.9 months11.4 months
Lexaria Bioscience Corp.LEXX$65.1M$3.5MMay 31, 2026$4.1M$8.7M12 months to Nov 30, 20254.8 months5.6 months
Oncolytics BiotechONCY$64.0M$4.1MJun 30, 2026$7.1M$22.7M12 months to Mar 31, 20262.2 months3.7 months
Biomea Fusion, Inc.BMEA$61.6M$34.8MJun 30, 2026$36.4M$56.4M12 months to Mar 31, 20267.4 months7.8 months
OS Therapies IncOSTX$59.5M$205.0KJun 30, 2026$3.6M$15.4M12 months to Mar 31, 20260.2 months2.8 months
Connect Biopharma Holdings LtdCNTB$55.8M$27.0MJun 30, 2026$38.6M$57.3M12 months to Mar 31, 20265.7 months8.1 months
IB Acquisition Corp.IBAC$54.4M$30.2KJun 30, 2026$256.5K$2.0M12 months to Dec 31, 20250.2 months1.5 months
Gain Therapeutics, Inc.GANX$54.3M$13.1MJun 30, 2026$15.0M$19.4M12 months to Mar 31, 20268.1 months9.3 months
Skye Bioscience, Inc.SKYE$54.2M$8.1MJun 30, 2026$11.0M$42.4M12 months to Mar 31, 20262.3 months3.1 months

Cash, current assets and operating cash flow: each company’s 10-Q and 10-K reports, from SEC EDGAR XBRL data. Click a cash figure for the filing.

Upcoming catalysts

Industry-sponsored trials with an estimated primary completion date (when the last patient’s main measurement is taken, so results usually follow within months) between Oct 21, 2026 and Apr 21, 2027. Phase 3 first, then by date. 1,507 phase 2 and phase 3 trials, 537 of them phase 3 (including phase 2/3); the first 80 are shown. Phase 1 studies are on ClinicalTrials.gov. Above them, the FDA advisory committee agenda item scheduled in the same period.

Month-by-month calendar

FDA advisory committee meetings

Advisory committees: the FDA advisory committee calendar.

Trial readouts

Primary completionSponsorDrugConditionPhaseStatusRecord
Oct 22, 2026AmgenDazodalibepA Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom StateSjögren's Syndrome (SS)Phase 3Active not recruitingNCT06245408
Oct 22, 2026Roche HoldingOcrelizumabA Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple SclerosisProgressive Multiple Sclerosis (PMS)Phase 3Active not recruitingNCT03523858
Oct 23, 2026Qilu Pharmaceutical Co., Ltd.3-6mg QLM1016, 10-20 mg Aripiprazole oral solution filmStudy on the Efficacy and Safety of QLM1016 in SchizophreniaSchizophreniaPhase 3Active not recruitingNCT06799559
Oct 26, 2026Csl LtdRecombinant single-chain factor VIII (rVIII-SingleChain)Recombinant Single-chain Factor VIII (rVIII-SingleChain) in Chinese Participants With Hemophilia A Previously Treated With FVIII ProductsCongenital Hemophilia APhase 3Active not recruitingNCT06738485
Oct 26, 2026Galderma Group AG/ADRNemolizumabA Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)Prurigo NodularisPhase 3Active not recruitingNCT04204616
Oct 26, 2026NovartisInclisiran sodium 300 mgCoronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic P…Coronary Artery DiseasePhase 3Active not recruitingNCT05360446
Oct 28, 2026AkesoCadonilimab (AK104), SugemalimabA Study of AK104 in Subjects With Unresectable Locally Advanced NSCLCNSCLC (Non-small Cell Lung Cancer)Phase 3RecruitingNCT06617416
Oct 28, 2026Albireo, an Ipsen CompanyOdevixibatAn Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary AtresiaBiliary AtresiaPhase 3Active not recruitingNCT05426733
Oct 28, 2026Roche HoldingRO7204239, RisdiplamA Study to Investigate the Safety and Efficacy of RO7204239 in Combination With Risdiplam (RO7034067) in Participants With Spinal Muscular A…Spinal Muscular Atrophy (SMA)Phase 2/3Active not recruitingNCT05115110
Oct 28, 2026Merck & Co.Belzutifan, PembrolizumabA Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Ca…Carcinoma, Renal CellPhase 3Active not recruitingNCT05239728
Oct 29, 2026Roche HoldingAfimkibartA Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to …Moderately to Severely Active Ulcerative ColitisPhase 3Active not recruitingNCT06588855
Oct 29, 2026NovartisIanalumab, CorticosteroidsStudy of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)Primary Immune Thrombocytopenia (ITP)Phase 3Active not recruitingNCT05653349
Oct 30, 2026CSPC Pharmaceutical Group–A Study of Prusogliptin Tablets Combined With Dapagliflozin Tablets and Metformin Hydrochloride Extended Release Tablets in Type 2 DiabetesType 2 DiabetesPhase 3Active not recruitingNCT07026968
Oct 30, 2026Kind Pharmaceuticals LLCAND017 capsules, ESAA Study of AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Patients With AnemiaAnemia Due to Chronic Kidney DiseasePhase 3RecruitingNCT07494409
Oct 30, 2026Laekna LimitedAfuresertibStudy to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast CancerBreast CancerPhase 3Active not recruitingNCT04851613
Oct 30, 2026Natureceuticals Sdn BhdNuvastatic 300Nuvastatic® Phase III Trial for Fatigue in Triple-Negative Breast CancerFatigue Related to Cancer Treatment, Breast CancerPhase 3RecruitingNCT07669467
Oct 30, 2026PfizerEncorafenib, Binimetinib, PembrolizumabA Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic MelanomaMelanomaPhase 3Active not recruitingNCT04657991
Oct 30, 2026Vertex PharmaceuticalsVX-121/TEZ/D-IVAA Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination TherapyCystic FibrosisPhase 3Active not recruitingNCT05444257
Oct 31, 2026AstraZenecaCapivasertib, FulvestrantCapivasertib+Fulvestrant asTreatment for Locally Advanced(Inoperable) or Metastatic HR+/HER2- Breast Cancer in Chinese PatientsBreast CancerPhase 3Active not recruitingNCT06635447
Oct 31, 2026Jiangsu Hengrui MedicineSHR6390Phase III Study ：SHR6390/Placebo Combined With Endocrine Therapy for the Adjuvant Treatment of Hormone Receptor Positive,Human Epidermal Rec…Hormone Receptor Positive,Human Epidermal Receptor 2 Negative, Node-positive, High Risk, Early Stage，Female Breast CancerPhase 3Active not recruitingNCT04842617
Oct 31, 2026Longboard Pharmaceuticals, Inc.LP352A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)Developmental and Epileptic EncephalopathyPhase 3Active not recruitingNCT06719141
Oct 31, 2026Natureceuticals Sdn BhdNuvastatic 300A Randomized, Double-blind, Placebo-controlled, Parallel-group, Comparative, Phase III Study to Evaluate the Efficacy and Safety of Nuvastat…Fatigue Related to Cancer Treatment, Colon CancerPhase 3RecruitingNCT07669454
Oct 31, 2026Olema Pharmaceuticals, Inc.Palazestrant, Fulvestrant, Anastrozole and 2 moreOP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast CancerBreast Cancer, Advanced Breast Cancer and 3 morePhase 3Active not recruitingNCT06016738
Oct 31, 2026Sarepta TherapeuticsEteplirsenA Study to Compare Safety and Efficacy of High Doses of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) (MIS51ON)Muscular Dystrophy, DuchennePhase 3Active not recruitingNCT03992430
Oct 31, 2026TG TherapeuticsUblituximabA Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Radiological and Clinical Effects of Subcutaneous Ublituximab in Partici…Relapsing Multiple SclerosisPhase 3Active not recruitingNCT07211633
Oct 31, 2026Takeda Pharmaceutical CompanyTAK-788, Pemetrexed, Cisplatin and 1 moreTAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutati…Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)Phase 3Active not recruitingNCT04129502
Oct 31, 2026Teva Pharmaceutical Industries Ltd.TEV-56248, Albuterol sulfateA Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma ExacerbationsAsthmaPhase 3Active not recruitingNCT06052267
Oct 31, 2026UCBStaccato alprazolamA Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged …Stereotypical Prolonged SeizuresPhase 3RecruitingNCT05077904
Nov 2026AbbVieUpadacitinib 15mg Dose, Dupilumab 300mg Dose, Upadacitinib 30mg DoseA Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to DupilumabAtopic DermatitisPhase 3Active not recruitingNCT06389136
Nov 2026Akesocadonilimab, pulocimab, paclitaxelA Study of AK104/Placebo Plus AK109/Placebo And Paclitaxel in Gastric or Gastroesophageal Junction AdenocarcinomaGastric and Gastroesophageal Junction AdenocarcinomaPhase 3RecruitingNCT06341335
Nov 2026CG Oncology, Inc.Cretostimogene Grenadenorepvec, n-dodecyl-B-D-maltosideA Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBTNon Muscle Invasive Bladder Cancer, Urologic Cancer and 2 morePhase 3Active not recruitingNCT06111235
Nov 2026CamurusCAM2029, Octreotide LAR, Lanreotide ATGA Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NETGastro-enteropancreatic Neuroendocrine TumorPhase 3Active not recruitingNCT05050942
Nov 2026Colgate-Palmolive CompanyColgate SNaP Total 10/10, 1.5 Taurate, Colgate Great Regular Flavor Toothpaste, Flat Trimmed Extra Clean TBTo Assess the Efficacy of Two Brushing Regimens: in the Reduction of Established Dental Plaque and Gingivitis.Plaque, Dental, GingivitisPhase 3Active not recruitingNCT07605338
Nov 2026DBV TechnologiesDBV712 250 mcgSafety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)Allergy, Peanut AllergyPhase 3Active not recruitingNCT07003919
Nov 2026Eli Lilly and CompanyTirzepatideA Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or OverweightType 1 Diabetes, Obesity and 1 morePhase 3Active not recruitingNCT06962280
Nov 2026Eli Lilly and CompanyTirzepatideA Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or OverweightType 1 Diabetes, Obesity and 1 morePhase 3Active not recruitingNCT06914895
Nov 2026Eli Lilly and CompanyRetatrutide, TirzepatideA Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have ObesityObesityPhase 3Active not recruitingNCT06662383
Nov 2026Immunic AGIMU-838 tabletsStudy to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingPhase 3Active not recruitingNCT05201638
Nov 2026Immunic AGIMU-838 tabletsStudy to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple SclerosisMultiple SclerosisPhase 3Active not recruitingNCT05134441
Nov 2026Lynk Pharmaceuticals Co., LtdLNK01001A Study to Evaluate Efficacy and Safety of LNK01001 in Adults With Ankylosing SpondylitisAnkylosing SpondylitisPhase 3RecruitingNCT07237568
Nov 2026Medicure IncPyridoxal PhosphateOral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO DeficiencyPyridox(am)Ine 5'-Phosphate Oxidase DeficiencyPhase 3RecruitingNCT04706013
Nov 2026Nanjing Chia-tai Tianqing PharmaceuticalNTQ5082 capsules 200 mg, Eculizumab InjectionA Phase III Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria PatientsParoxysmal Nocturnal HemoglobinuriaPhase 3Not yet recruitingNCT07177859
Nov 2026NewAmsterdam Pharma Co N.V.ObicetrapibCardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular DiseaseAtherosclerotic Cardiovascular DiseasePhase 3Active not recruitingNCT05202509
Nov 2026Nuance HearingSpectacle Hearing AidA Prospective, Open-label, Pivotal Study to Assess Spectacle Hearing Aid Safety and EfficacyHearing Loss MixedPhase 2/3RecruitingNCT07282028
Nov 2026SandozCYB704, Ocrevus-EU, Ocrevus-USComparative PK, PD, Efficacy, and Safety Assessment of the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing…Relapsing Multiple SclerosisPhase 3Active not recruitingNCT06847724
Nov 2026Sichuan Baili Pharmaceutical Co., Ltd.BL-B01D1, capecitabine, gemcitabine and 1 moreA Study Comparing BL-B01D1 With Physician's Choice of Chemotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma(PANKU-N…Nasopharyngeal CarcinomaPhase 3Active not recruitingNCT06118333
Nov 2026Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.SKB264, PembrolizumabA Study of SKB264 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Locally Advanced or Metastatic Non-Small Cell Lung…Non-Small Cell Lung CancerPhase 3Active not recruitingNCT06448312
Nov 2026Sinovac Biotechexperimental vaccine, active comparator vaccinePhase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 2-6 YearsEpidemic Meningitis, Meningococcal VaccinesPhase 3Active not recruitingNCT07505888
Nov 2026Waterstone Pharmaceutical (Wuhan) Co., LTD.WS016A Two-Part, Phase 3 Study Evaluating the Efficacy and Safety of WS016 for the Treatment of HyperkalemiaHyperkalemiaPhase 3RecruitingNCT07251309
Nov 2026Wooshin Labottach Co., Ltd.Cosmetic patch containing urea applicated daily for 3 monthsStudy to Assess Efficacy, Safety and Tolerability of a Nail Patch in Patients With Nail Fragility, Mychosis, PsoriasisNail Psoriasis, Nail Damage and 1 morePhase 3RecruitingNCT07029516
Nov 2026medac GmbHMethotrexateEfficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.Moderate to Severe Atopic DermatitisPhase 3RecruitingNCT06239311
Nov 1, 2026Bristol-Myers SquibbKarXTA Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I DisorderBipolar-I Disorder With Mania or Mania With Mixed FeaturesPhase 3RecruitingNCT06951698
Nov 1, 2026EpygenixClemizole HClAn Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut SyndromeLennox Gastaut SyndromePhase 3RecruitingNCT05066217
Nov 1, 2026Scholar Rock, Inc.ApitegromabLong-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of ApitegromabSpinal Muscular Atrophy, Spinal Muscular Atrophy Type 3 and 8 morePhase 3Active not recruitingNCT05626855
Nov 2, 2026AstraZenecaAnifrolumabA Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus ErythematosusCutaneous Lupus ErythematosusPhase 3Active not recruitingNCT06015737
Nov 2, 2026Bristol-Myers SquibbKarXTA Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)Bipolar Disorder Type I With Mania or Mania With Mixed FeaturesPhase 3RecruitingNCT06951711
Nov 2, 2026Teva Pharmaceutical Industries Ltd.Fp/ABS, FP, ABSA Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Parti…AsthmaPhase 3Active not recruitingNCT06664619
Nov 3, 2026NovartisLOU064 (blinded)24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and …Chronic Spontaneous UrticariaPhase 3Active not recruitingNCT05677451
Nov 4, 2026CMG Pharmaceutical Co. LtdCMG190303(Dapagliflozin/Rosuvastatin)Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and DyslipidemiaDyslipidemia, Type 2 DiabetesPhase 3RecruitingNCT06772168
Nov 9, 2026LEAF4Life, Inc.LEAF-4L6715, Supportive CareEfficacy and Safety of LEAF-4L6715 for Acute Respiratory Distress SyndromeAcute Respiratory Distress SyndromePhase 3Not yet recruitingNCT06640777
Nov 10, 2026Gan & Lee Pharmaceuticals Co., Ltd.GZR4, Insulin Icodec groupA Phase IIIb Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal InsulinDiabetesPhase 3RecruitingNCT07165223
Nov 10, 2026LaNova Medicines Zhejiang Co., Ltd.LM-302, Apatinib, IrinotecanLM-302 for the Treatment of Subjects With Claudin18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma.Locally Advanced or Metastatic GC and GCJ AdenocarcinomaPhase 3Active not recruitingNCT06351020
Nov 11, 2026AstraZenecaTrastuzumab deruxtecan, Taxane, Pertuzumab and 1 moreTrastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cance…Breast Cancer; HER2-positive; MetastaticPhase 3Active not recruitingNCT04784715
Nov 11, 2026Tasly Pharmaceutical Group Co., LtdChangkang granulesEfficacy and Safety of Changkang Granules in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea (Liver qi Affecting the Spl…Diarrhea-predominant Irritable Boewl SyndromePhase 3Not yet recruitingNCT06753890
Nov 12, 2026Qilu Pharmaceutical Co., Ltd.RelugolixEfficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine FibroidsHeavy Menstrual Bleeding, Uterine FibroidsPhase 3RecruitingNCT06671548
Nov 13, 2026Roche HoldingInavolisib, Fulvestrant, Alpelisib and 3 moreA Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-P…Breast CancerPhase 3RecruitingNCT05646862
Nov 14, 2026BrightGene Bio-Medical Technology Co.5 mg BGM0504 Administered SC, 10 mg BGM0504 Administered SC, Semaglutide Administered SCA Study of BGM0504 in Participants With Type 2 DiabetesType 2 Diabetes Mellitus (T2DM)Phase 3Active not recruitingNCT06716216
Nov 14, 2026BrightGene Bio-Medical Technology Co.5 mg BGM0504 Administered SC, : 10 mg BGM0504 Administered SCA Study of BGM0504 in Poorly Controlled Type 2 Diabetes Patients Only Through Diet and ExerciseType 2 Diabetes Mellitus (T2DM)Phase 3Active not recruitingNCT06716203
Nov 15, 2026Achieve Life Sciences, INC.Cytisinicline, Behavioral SupportPhase 3 Trial Evaluating the Efficacy and Safety of Cytisinicline for Vaping Cessation in Adults Using Nicotine-Containing E CigarettesVaping CessationPhase 3Not yet recruitingNCT07392125
Nov 16, 2026UCBZilucoplanA Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia GravisGeneralized Myasthenia GravisPhase 2/3RecruitingNCT06055959
Nov 18, 2026Bristol-Myers SquibbDeucravacitinibA Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's SyndromeSjögren's SyndromePhase 3Active not recruitingNCT05946941
Nov 18, 2026Han Xu, M.D., Ph.D., FAPCR, Medical Director,, IRB ChairETOPOSIDE - Usual, ETOPOSIDE - StudyPharmacogenomics ANDA SNP Clinical Study - Etoposide and Single Nucleotide PolymorphismsSmall Cell Lung CancerPhase 2/3Active not recruitingNCT01064466
Nov 18, 2026Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB ChairAbiraterone - Usual, Abiraterone - StudyPharmacogenomics IND Commercial SNP Clinical Study - Abiraterone and Single Nucleotide PolymorphismsProstate CancerPhase 2/3Active not recruitingNCT03348670
Nov 18, 2026Medicine Invention Design, IncALECENSA - alectinib hydrochloride capsulePharmacogenomics IND SNP Clinical Trial - Alectinib and Single Nucleotide PolymorphismsALK-Positive Non-Small Cell Lung Cancer (NSCLC)Phase 2/3Active not recruitingNCT05987956
Nov 20, 2026Merck & Co.Pembrolizumab, Carboplatin, Paclitaxel and 5 moreStudy of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed…Endometrial NeoplasmsPhase 3Active not recruitingNCT04634877
Nov 21, 2026Changchun GeneScience Pharmaceutical Co., Ltd.Cabergoline tablets, Bromocriptine mesylate tabletsA Phase III Clinical Study of Cabergoline Tablets Compared With Bromocriptine Mesylate TabletsHyperprolactinemiaPhase 3RecruitingNCT07124221
Nov 23, 2026GSKdTpaA Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Japanese Healt…Diphtheria-Tetanus-acellular Pertussis VaccinesPhase 3Active not recruitingNCT07596199
Nov 23, 2026GSKInvestigational varicella vaccine, Marketed varicella vaccine, Measles, mumps, and rubella vaccine and 4 moreA Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of AgeChickenpoxPhase 3RecruitingNCT06693895
Nov 24, 2026Merck KGaAAvelumabAvelumab Program Rollover StudySolid TumorsPhase 3Active not recruitingNCT03815643
Nov 24, 2026HTA Co., Ltd.177Lu-DOTATATE injection, Octreotide LAR (Long-acting release)A Phase III Clinical Study to Compare the Safety and Efficacy of 177Lu-DOTATATE Injection and Long-acting Oxytrexine in Adult Patients With …NETS Ga68 Lu177Phase 3RecruitingNCT07057622

Trials: ClinicalTrials.gov, the U.S. National Library of Medicine’s registry, industry-sponsored studies only. Completion dates are the sponsor’s own estimates and often slip. Retrieved Oct 21, 2026.

Recent FDA approvals

Original approvals of new drug applications (NDAs) and biologics license applications (BLAs) in the 12 months to Oct 16, 2026, newest first: 139 in all, 59 of them new molecular entities (the FDA’s type 1, for drugs and biologics alike). Supplements (new uses, doses and labeling changes) are left out, as are 690 first approvals of generics (ANDAs).

New molecular entities

Other original approvals

New dosage forms, formulations, combinations, new active ingredients and biosimilars; the latest 40 of 80.

ApprovedProductSponsorKind
Oct 16Brytlybrytly (apraclonidine)AlconNew formulation or new manufacturer
Oct 15Evoxaccevimeline hydrochlorideCosette Pharms NcNew dosage form
Oct 9Isovue ReadiiopamidolBraccoNew formulation or new manufacturer
Oct 8Breztri Aerospherebudesonide, glycopyrrolate, and formoterol fumarateAstraZenecaNew formulation or new manufacturer
Oct 8WeltruzaolanzapineTeva Pharmaceutical Industries Ltd.New formulation or new manufacturer
Oct 1TrabectedintrabectedinEverNew formulation or new manufacturer
Sep 25Zueinodiclofenac sodiumAdventapharmaNew formulation or new manufacturer
Sep 25Degevmadenosumab-adetTeva Pharmaceutical Industries Ltd.New formulation or new manufacturer
Sep 25Lamliquelamotrigine hemifumarateAzurityNew active ingredient
Sep 15Garzulysinsulin aspart-fsanEmerge Bioscience Pte. Ltd.BLA
Sep 14Bexlutrylutetium lu-177 dotatateCuriumNew formulation or new manufacturer
Sep 3Omcaziocabozantinib laurylsulfateHanda OncolNew formulation or new manufacturer
Aug 27Bixlenvo Sunlenca Starter Pack (copackaged)bictegravir sodium, lenacapavir sodium; lenacapavir sodiumGilead SciencesNew combination
Aug 27Bixlenvobictegravir sodium; lenacapavir sodiumGilead SciencesNew combination
Aug 26Vobrigleuprolide acetateSun PharmaceuticalNew formulation or new manufacturer
Aug 14Sodium Bicarbonatesodium bicarbonateBaxter InternationalNew formulation or new manufacturer
Jul 31Zimrixbyrituximab-cdxxDr Reddys Labs SaBLA
Jul 29Qlonilikclonidine hydrochlorideCmp Dev LlcNew formulation or new manufacturer
Jul 29Glycophossodium glycerophosphateFresenius KabiNew active ingredient
Jul 28Gwyn Loethinyl estradiol; norelgestrominViatrisNew formulation or new manufacturer
Jul 24Tylenol With Naproxenacetaminophen; naproxen sodiumKenvueNew combination
Jul 24Garzulysinsulin aspart-fsanEmerge Bioscience Pte. Ltd.BLA
Jul 10Zyogreenindocyanine greenProvepharm SasNew dosage form
Jul 9Sarclisa Escenaisatuximab-irfcSanofiNew dosage form
Jul 9Sodium Bicarbonatesodium bicarbonateAmneal Pharmaceuticals, Inc.New formulation or new manufacturer
Jun 24Navitruxfosaprepitant dimeglumineAvyxa HoldingsNew formulation or new manufacturer
Jun 16AprepitantaprepitantAzurityNew formulation or new manufacturer
Jun 2TiocystintioproninCasper Pharma LlcNew formulation or new manufacturer
Jun 2Ranluspecranibizumab-hkdzLupin Ltd.New active ingredient
May 29CavhanzanilotinibCycleNew formulation or new manufacturer
May 22Differin Epiduo Acne Gel (adapalene And Benzoyl Peroxide)adapalene, benzoyl peroxide; adapalene; benzoyl peroxideGalderma Group AG/ADRPartial rx to otc switch
May 15Immgolisgolimumab-sldiAccord Biopharma Inc.New formulation or new manufacturer
May 14Trimbowbeclomethasone dipropionate; formoterol fumarate; glycopyrrolateChiesiNew combination
May 7Ennumopegfilgrastim-pccgAccord Biopharma Inc.BLA
May 1Jakafi Xrruxolitinib phosphateIncyteNew formulation or new manufacturer
May 1EvditrabectedinApotexNew formulation or new manufacturer
Apr 29Langlarainsulin glargine-aldySunshine Lake Pharma Co LtdBLA
Apr 24Saphneloanifrolumab-fniaAstraZenecaNew formulation or new manufacturer
Mar 30EpinephrineepinephrineBaxter InternationalNew combination and new formulation or new manufacturer
Mar 27Ponlimsidenosumab-adetTeva Pharmaceutical Industries Ltd.New formulation or new manufacturer

Approvals: Drugs@FDA, the FDA’s database of approved drugs and biologics reviewed by its drug center (CDER). Vaccines and blood products reviewed by CBER are not in it.

Insider buying

Open-market purchases of shares from Jul 23, 2026 to Oct 21, 2026: 271 filings at 101 companies, $633.1M in all, by trade date. Each row is one Form 4; click the value for the filing.

Officers and directors

The largest 25 of 225 purchases by people who run the company or sit on its board (some also own 10% or more).

CompanyBuyerDateSharesValue
Kodiak Sciences Inc.KOD667, L.P.Director, 10% ownerSep 28–Sep 29715,592$63.4M
Kodiak Sciences Inc.KODBaker Bros. Advisors (GP) LLCDirector, 10% ownerSep 28807,840$58.6M
Scribe Therapeutics, Inc.SCTXAvoro Ventures LLCDirectorJul 24–Jul 282,391,238$36.3M
Kodiak Sciences Inc.KODBAKER JULIANDirector, 10% ownerSep 28418,323$35.0M
Braveheart Bio, Inc.BRVEChimovits Erez; OrbiMed Genesis GP LLCDirector, 10% ownerAug 71,940,000$34.9M
Electra Therapeutics, Inc.ETRAGORDON CARL L; OrbiMed Capital GP VII LLCDirector, 10% ownerSep 211,333,333$20.0M
ADARx Pharmaceuticals, Inc.ADRXGORDON CARL L; OrbiMed Genesis GP LLCDirector, 10% ownerSep 28950,000$16.1M
Scribe Therapeutics, Inc.SCTXGORDON CARL L; ORBIMED ADVISORS LLCDirectorJul 271,000,000$15.0M
Alumis INC.ALMSAKKARAJU SRINIVASDirectorSep 4–Sep 8986,721$10.7M
Attovia Therapeutics, Inc.ATTOWALSH COLIN; GOLDMAN SACHS ASSET MANAGEMENT, L.P. and 1 moreDirectorAug 5–Aug 6585,000$10.3M
BlossomHill Therapeutics, Inc.BLSMGORDON CARL L; OrbiMed Capital GP VIII LLCDirectorAug 10625,000$10.0M
Apollomics Inc.APLMChen Hung-WenChief Executive Officer, DirectorAug 14536,667$7.6M
Immatics N.V.IMTXEDELMAN JOSEPHDirectorAug 26863,060$7.5M
Inhibrx Biosciences, Inc.INBXLappe MarkChief Executive Officer, DirectorSep 825,000$2.6M
Outlook Therapeutics, Inc.OTLKSukhtian Ghiath M.Director, 10% ownerAug 122,525,252$2.5M
Braveheart Bio, Inc.BRVEViehbacher Christopher; Murdoch TravisDirectorAug 783,333$1.5M
Helus Pharma Inc.HELPHalstead MichaelChief Executive OfficerSep 21100,000$1.3M
Helus Pharma Inc.HELPGlavine Paul; So Eric H. L.Chief Growth OfficerSep 8100,000$1.2M
Kura OncologyKURAWILSON TROY EDWARDPresident and CEO, DirectorAug 24100,000$1.2M
Helus Pharma Inc.HELPSo Eric H. L.Executive Chair, DirectorSep 4100,000$1.2M
Helus Pharma Inc.HELPGlavine PaulChief Growth OfficerSep 3100,000$1.2M
Helus Pharma Inc.HELPSo Eric H. L.Executive Chair, DirectorSep 195,000$1.1M
Kura OncologyKURAWILSON TROY EDWARDPresident and CEO, DirectorAug 17100,000$1.1M
Ionis Pharmaceuticals IncIONSHayden Michael RDirectorJul 30–Jul 3120,000$1.1M
ADARx Pharmaceuticals, Inc.ADRXChimovits ErezDirectorSep 2861,516$1.0M

Large shareholders

The largest 25 of 46 purchases by owners of 10% or more with no board seat, usually venture and hedge funds, often buying in a stock sale or IPO.

CompanyBuyerDateSharesValue
Braveheart Bio, Inc.BRVEForbion Growth Opportunities Fund III Cooperatief U.A.10% ownerAug 73,600,000$64.8M
MapLight Therapeutics, Inc.MPLTCatalyst4, Inc.10% ownerAug 144,400,000$50.1M
ADARx Pharmaceuticals, Inc.ADRXSR ONE CAPITAL MANAGEMENT, LLC; George Simeon10% ownerSep 281,600,000$27.2M
Braveheart Bio, Inc.BRVEAndreessen Marc L10% ownerAug 71,100,000$19.8M
MapLight Therapeutics, Inc.MPLTCatalyst4, Inc.10% ownerJul 28–Jul 301,209,225$15.3M
Zentalis Pharmaceuticals, Inc.ZNTLWALTERS WILLIAM THURMAN10% ownerAug 144,335,000$15.2M
Attovia Therapeutics, Inc.ATTOGreen Jeremy10% ownerAug 6600,000$10.2M
Attovia Therapeutics, Inc.ATTOFHMLS XI, L.P.10% ownerAug 6588,235$10.0M
Attovia Therapeutics, Inc.ATTOvenBio Global Strategic Fund IV, L.P.10% ownerAug 6382,352$6.5M
Attovia Therapeutics, Inc.ATTOSanofi10% ownerAug 6300,000$5.1M
Apnimed, Inc.APMDMorningside Venture Investments Ltd10% ownerAug 3312,500$5.0M
BlossomHill Therapeutics, Inc.BLSMCormorant Private Healthcare Fund VI, LP10% ownerAug 10312,500$5.0M
Scribe Therapeutics, Inc.SCTXAH Equity Partners Bio II, L.L.C.10% ownerJul 27333,333$5.0M
Sol-Gel Technologies Ltd.SLGLOpaleye Management Inc.10% ownerAug 28–Aug 3140,330$2.8M
Latigo Biotherapeutics, Inc.LTGOForesite Capital Fund VI LP; Tananbaum James B.10% ownerAug 10140,000$2.5M
Nature's Sunshine ProductsNATRPRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.10% ownerAug 6–Aug 10141,389$2.3M
Tenax Therapeutics, INC.TENXSchneeberger Daniel10% ownerAug 20–Aug 241,025,867$1.8M
NextCure, Inc.NXTCADAR1 Capital Management, LLC10% ownerJul 30–Jul 31329,153$1.6M
Tenax Therapeutics, INC.TENXADAR1 Capital Management, LLC10% ownerSep 3900,000$1.6M
Prothena Corp Public Ltd CoPRTASCULLY WILLIAM P10% ownerSep 29162,000$1.4M
Tenax Therapeutics, INC.TENXSchneeberger Daniel10% ownerAug 31–Sep 2770,333$1.4M
Alpha Cognition Inc.ACOGOpaleye Management Inc.10% ownerSep 14–Sep 16123,918$1.1M
Eikon Therapeutics, Inc.EIKNKutzkey Tim10% ownerSep 389,200$1.0M
Prothena Corp Public Ltd CoPRTASCULLY WILLIAM P10% ownerSep 28103,500$890.1K
Prothena Corp Public Ltd CoPRTASCULLY WILLIAM P10% ownerSep 18100,000$843.0K

Insider trades: Form 4 filings on SEC EDGAR. Open-market purchases (transaction code P) of shares only, not options or grants.

Most shorted

Short interest as a share of all shares outstanding, as of FINRA’s Sep 30, 2026 report, for the 30 most shorted U.S.-listed companies here worth $300 million or more. Change is from the previous report, two weeks earlier.

Every stock’s short interest
CompanyOf sharesShares shortChangeDays to coverMarket value
C4 Therapeutics (United States)CCCC32.8%40,395,665+0.5%17.6$354.9M
Capricor Therapeutics, INC.CAPR32.4%18,825,352−4.3%4.5$385.8M
Intellia TherapeuticsNTLA32.2%45,110,513−3.4%9.5$1.6B
Recursion PharmaceuticalsRXRX29.5%157,938,412−11.6%6.1$1.9B
NovavaxNVAX27.9%46,046,946−7.7%8.1$1.8B
Galena BiopharmaSLS27.3%55,128,974−6.7%9.4$2.1B
Beam TherapeuticsBEAM26.7%27,548,815+6.4%15.3$2.5B
Tango Therapeutics (United States)TNGX26.4%44,500,110+6.3%12.5$4.0B
Neurogene Inc.NGNE24.9%4,974,749+51.7%11.7$478.1M
Replimune Group, Inc.REPL24.5%23,128,025+1.6%10.8$1.0B
Editas MedicineEDIT24.2%37,109,260+23.9%9.3$360.9M
Vera Therapeutics, Inc.VERA23.9%17,240,397+1.2%7.8$2.1B
Altimmune, Inc.ALT23.7%46,079,911−11.0%10.5$431.8M
Inhibrx Biosciences, Inc.INBX23.3%3,432,642+1.1%11.8$1.3B
Monte Rosa TherapeuticsGLUE23.1%19,686,241+2.2%18.0$906.9M
Aquestive Therapeutics, Inc.AQST22.9%28,748,212+5.8%13.1$471.3M
Viking TherapeuticsVKTX22.2%25,921,759+14.8%2.2$2.9B
Xencor IncXNCR22.0%16,368,875+3.9%10.1$1.7B
Absci CorpABSI21.8%37,442,385+0.5%7.5$1.5B
QuidelQDEL21.8%14,953,442+5.4%11.0$873.7M
Sarepta TherapeuticsSRPT21.6%22,784,187−10.4%8.6$1.9B
Annexon, Inc.ANNX21.4%32,009,914−2.6%8.9$577.9M
Relay TherapeuticsRLAY21.3%46,746,942+5.1%12.6$3.7B
Silverback TherapeuticsSPRY21.3%21,190,047−8.2%16.1$426.1M
Avalo Therapeutics, Inc.AVTX21.3%11,405,304−11.8%8.8$621.0M
Savara IncSVRA21.2%43,563,969+0.5%17.2$965.7M
Corvus Pharmaceuticals, Inc.CRVS21.2%17,797,751+3.6%13.3$808.4M
Harrow HealthHROW20.7%7,762,798+3.7%12.4$1.1B
Ultragenyx Pharmaceutical Inc.RARE20.6%20,349,877+22.8%3.1$1.5B
Syndax Pharmaceuticals IncSNDX20.4%18,234,880−11.7%8.5$1.2B

Short interest: FINRA equity short interest, reported by broker-dealers twice a month for every exchange-listed and over-the-counter stock. Shares outstanding come from each company’s latest SEC filing; prices from our market snapshot.

Every company

988 biotech and drug companies with a share price or recent SEC financials, largest first. Click a column to sort; type to filter.

CompanySEC industryMarket valuePast yearCashRunway on cashShort % of sharesActive phase 3 trialsOriginal NDAs and BLAs
Eli Lilly and CompanyLLYPharmaceutical Preparations$1.2T+55.9%$8.9BCash-generating0.7%9389
Johnson & JohnsonJNJPharmaceutical Preparations$612.9B+31.6%$20.4BCash-generating0.9%81139
AbbVieABBVPharmaceutical Preparations$502.0B+23.8%$6.6BCash-generating0.9%71191
Merck & Co.MRKPharmaceutical Preparations$355.1B+69.8%$6.8BCash-generating1.1%106178
NovartisNVSPharmaceutical or biotech (Wikidata)$292.1B+14.5%$11.4BCash-generating0.3%93167
AstraZenecaAZNPharmaceutical Preparations$261.6B−2.5%$5.7BCash-generating0.2%19182
AmgenAMGNBiological Products, (No Diagnostic Substances)$231.3B+43.2%$14.0BCash-generating2.6%5034
Gilead SciencesGILDBiological Products, (No Diagnostic Substances)$191.7B+25.9%$3.2BCash-generating1.8%3238
Abbott LaboratoriesABTPharmaceutical Preparations$180.8B−19.2%$6.8BCash-generating0.8%029
NovoNVOPharmaceutical Preparations$173.2B−29.1%––0.7%4520
PfizerPFEPharmaceutical Preparations$168.0B+20.3%$976.0MCash-generating2.6%94470
Vertex PharmaceuticalsVRTXPharmaceutical Preparations$127.2B+20.4%$6.1BCash-generating1.8%1710
Bristol-Myers SquibbBMYPharmaceutical Preparations$120.9B+35.6%$8.7BCash-generating2.2%8176
GSKGSKPharmaceutical Preparations$100.3B+12.9%––0.7%77140
SanofiSNYPharmaceutical Preparations$98.4B−21.6%––0.4%54111
ModernaMRNABiological Products, (No Diagnostic Substances)$90.5B+771.5%$1.7B14.1 months7.7%20
Regeneron PharmaceuticalsREGNPharmaceutical Preparations$82.8B+35.8%$2.5BCash-generating2.0%389
WuXi AppTec2359.HKPharmaceutical or biotech (Wikidata)$75.8B+85.1%–––00
Takeda Pharmaceutical CompanyTAKPharmaceutical Preparations$63.7B+39.8%––0.1%4563
Argenx SEARGXBiological Products, (No Diagnostic Substances)$55.7B−2.1%$3.5BCash-generating2.0%172
Siemens HealthineersSMMNYPharmaceutical or biotech (Wikidata)$52.3B−18.1%––0.0%00
BayerBAYN.FPharmaceutical or biotech (Wikidata)$49.2B+60.7%–––1099
Teva Pharmaceutical Industries Ltd.TEVAPharmaceutical Preparations$48.2B+114.3%$3.7BCash-generating2.6%2109
Jiangsu Hengrui Medicine600276.SSPharmaceutical or biotech (Wikidata)$47.1B−30.2%–––760
Sun PharmaceuticalSUNPHARMA.NSPharmaceutical or biotech (Wikidata)$44.1B+6.0%–––955
IQVIA Holdings, Inc.IQVCommercial Physical & Biological Research$44.1B+29.2%$1.9BCash-generating1.9%00
IDEXX Laboratories, Inc.IDXXIn Vitro & In Vivo Diagnostic Substances$44.1B−12.0%$196.9MCash-generating2.5%00
BeOne Medicines Ltd.ONCPharmaceutical Preparations$43.9B+17.5%$5.1BCash-generating1.6%197
SandozSDZ.SWPharmaceutical or biotech (Wikidata)$41.1B+58.2%–––159
Revolution Medicines (United States)RVMDBiological Products, (No Diagnostic Substances)$39.0B+236.6%$815.4M9.3 months5.6%00
Royalty Pharma plcRPRXPharmaceutical Preparations$36.1B+63.4%$812.0MCash-generating2.2%00
BiogenBIIBBiological Products, (No Diagnostic Substances)$34.5B+63.3%$3.4BCash-generating4.0%1712
ZoetisZTSPharmaceutical Preparations$32.9B−44.7%$1.5BCash-generating4.5%00
Alnylam PharmaceuticalsALNYPharmaceutical Preparations$31.5B−51.1%$1.7BCash-generating5.8%54
Astellas Pharma4503.TPharmaceutical or biotech (Wikidata)$28.2B+50.0%–––1327
Zai Lab LimitedZLABPharmaceutical Preparations$26.9B−15.1%$607.5M72 months0.6%00
Hansoh Pharmaceutical Group3692.HKPharmaceutical or biotech (Wikidata)$26.6B−11.2%–––190
WuXi Biologics2269.HKPharmaceutical or biotech (Wikidata)$25.9B+31.5%–––00
Divi's LaboratoriesDIVISLAB.NSPharmaceutical or biotech (Wikidata)$25.7B+37.2%–––00
RoivantROIVPharmaceutical Preparations$25.3B+102.8%$1.2B18.3 months5.4%00
Genmab A/sGMABPharmaceutical Preparations$24.2B+16.3%$1.7BCash-generating1.0%151
Sartorius Stedim BiotechDIM.PAPharmaceutical or biotech (Wikidata)$23.5B+4.5%–––00
UNITED THERAPEUTICS CorpUTHRPharmaceutical Preparations$23.4B+25.6%$1.8BCash-generating8.4%36
BioNTechBNTXBiological Products, (No Diagnostic Substances)$23.0B−15.2%––1.0%70
IncyteINCYCommercial Physical & Biological Research$22.7B+29.9%$3.5BCash-generating5.0%226
ViatrisVTRSPharmaceutical Preparations$20.9B+79.2%$886.5MCash-generating3.7%674
INSMED IncINSMPharmaceutical Preparations$20.9B−42.3%$544.8M7.3 months6.3%53
StraumannSAUHYPharmaceutical or biotech (Wikidata)$18.7B+2.3%––0.0%00
Torrent PharmaceuticalsTORNTPHARM.NSPharmaceutical or biotech (Wikidata)$18.2B+29.0%–––00
MedpaceMEDPCommercial Physical & Biological Research$17.4B+17.9%$502.7MCash-generating5.7%00
Shionogi4507.TPharmaceutical or biotech (Wikidata)$16.2B+21.4%–––28
Ascendis Pharma A/SASNDPharmaceutical Preparations$15.8B+9.5%––5.1%20
ExelixisEXELBiological Products, (No Diagnostic Substances)$15.5B+59.5%$281.4MCash-generating11.4%102
Charles River LaboratoriesCRLBiological Products, (No Diagnostic Substances)$14.3B+67.8%$192.0MCash-generating6.0%00
ICON plcICLRCommercial Physical & Biological Research$14.3B−9.3%$647.3MCash-generating3.3%00
Yunnan Baiyao Group000538.SZPharmaceutical or biotech (Wikidata)$14.1B−8.0%–––00
Neurocrine BiosciencesNBIXBiological Products, (No Diagnostic Substances)$14.0B−1.9%$332.4MCash-generating5.8%124
Halozyme TherapeuticsHALOBiological Products, (No Diagnostic Substances)$14.0B+83.4%$163.1MCash-generating13.5%12
Jazz PharmaceuticalsJAZZPharmaceutical Preparations$13.4B+52.2%$1.6BCash-generating8.4%77
BridgeBioBBIOPharmaceutical Preparations$13.3B+24.1%$677.9M18.3 months10.1%00
CSPC Pharmaceutical Group1093.HKPharmaceutical or biotech (Wikidata)$12.6B−4.2%–––401
Summit TherapeuticsSMMTPharmaceutical Preparations$12.6B−24.9%$419.4M13.1 months5.2%50
Corcept TherapeuticsCORTPharmaceutical Preparations$12.1B+42.8%$111.0MCash-generating7.9%12
ElancoELANPharmaceutical Preparations$11.8B+10.1%$530.0MCash-generating7.5%00
Bio-TechneTECHBiological Products, (No Diagnostic Substances)$11.4B+17.2%$264.7MCash-generating4.7%00
CiplaCIPLA.NSPharmaceutical or biotech (Wikidata)$11.2B−16.1%–––021
Dr. Reddy's LaboratoriesRDYPharmaceutical Preparations$11.0B−9.4%––3.4%00
BioMarin PharmaceuticalBMRNPharmaceutical Preparations$10.6B+2.7%$874.0MCash-generating6.0%68
Madrigal Pharmaceuticals, INC.MDGLPharmaceutical Preparations$10.3B+1.4%$292.7M13.1 months10.4%31
RepligenRGENBiological Products, (No Diagnostic Substances)$9.9B+15.4%$606.8MCash-generating13.4%00
QiagenQGENBiological Products, (No Diagnostic Substances)$9.9B−3.1%$839.0MCash-generating3.6%00
Vaxcyte, Inc.PCVXBiological Products, (No Diagnostic Substances)$9.7B+53.9%$183.2M2.9 months11.6%20
Aurobindo PharmaAUROPHARMA.NSPharmaceutical or biotech (Wikidata)$9.6B+47.3%–––015
Krystal Biotech, Inc.KRYSBiological Products, (No Diagnostic Substances)$9.5B+68.5%$427.7MCash-generating11.7%10
Lupin Ltd.LUPIN.NSPharmaceutical or biotech (Wikidata)$9.5B+0.5%–––313
ImmunityBio, Inc.IBRXBiological Products, (No Diagnostic Substances)$9.1B+256.0%$75.7M3.1 months11.7%20
Eisai4523.TPharmaceutical or biotech (Wikidata)$9.0B+8.7%–––315
Kymera TherapeuticsKYMRBiological Products, (No Diagnostic Substances)$9.0B+80.5%$124.5M6.2 months11.9%00
Twist BioscienceTWSTBiological Products, (No Diagnostic Substances)$8.8B+399.6%$117.4M28 months16.9%00
CytokineticsCYTKPharmaceutical Preparations$8.7B+7.4%$255.3M5.8 months13.9%41
Protagonist Therapeutics, IncPTGXPharmaceutical Preparations$8.7B+72.9%$420.1M43 months14.4%20
TG TherapeuticsTGTXPharmaceutical Preparations$8.2B+54.1%$482.6Mover 10 years20.0%41
Abivax S.A.ABVXPharmaceutical Preparations$8.2B−4.3%––8.4%10
Axsome TherapeuticsAXSMPharmaceutical Preparations$8.2B+21.7%$319.9M54 months6.3%102
ALK-AbellóALK-B.COPharmaceutical or biotech (Wikidata)$8.1B+12.9%–––00
Arrowhead PharmaceuticalsARWRPharmaceutical Preparations$8.0B+54.1%$54.8MCash-generating7.6%41
Aeglea BioTherapeuticsSYREPharmaceutical Preparations$7.5B+280.8%$162.0M10.5 months14.6%00
Ono Pharmaceutical4528.TPharmaceutical or biotech (Wikidata)$7.4B+34.1%–––80
Ionis Pharmaceuticals IncIONSPharmaceutical Preparations$7.3B−39.7%$350.1M4.6 months13.5%123
Praxis Precision Medicines, Inc.PRAXPharmaceutical Preparations$7.2B+36.6%$474.8M20.2 months15.0%60
AlkermesALKSPharmaceutical Preparations$7.1B+40.3%$511.5MCash-generating10.6%66
HD Medicine000963.SZPharmaceutical or biotech (Wikidata)$7.0B−35.8%–––00
Lantheus Holdings, Inc.LNTHIn Vitro & In Vivo Diagnostic Substances$6.5B+79.9%$593.3MCash-generating5.8%17
Pharmaron3759.HKPharmaceutical or biotech (Wikidata)$6.4B+7.7%–––00
Alkem LaboratoriesALKEM.NSPharmaceutical or biotech (Wikidata)$6.3B−10.3%–––01
Iovance BiotherapeuticsIOVABiological Products, (No Diagnostic Substances)$6.3B+538.5%$110.8M4.9 months14.3%10
Kiniksa Pharmaceuticals International, plcKNSAPharmaceutical Preparations$6.3B+105.5%$190.0MCash-generating4.8%11
Sinopharm Group1099.HKPharmaceutical or biotech (Wikidata)$6.2B−15.7%–––00
Belite Bio, IncBLTEPharmaceutical Preparations$6.2B+65.8%$352.9M115 months2.5%20
ActavisACTPharmaceutical Preparations$6.2B+29.8%––2.0%00
Amneal Pharmaceuticals, Inc.AMRXPharmaceutical Preparations$6.2B+94.6%$127.6MCash-generating3.5%113
Rhythm (United states)RYTMPharmaceutical Preparations$6.1B−20.0%$65.6M6.6 months15.6%00
Ligand Pharmaceuticals IncLGNDPharmaceutical Preparations$6.0B+64.7%$1.0BCash-generating13.4%01
Kodiak Sciences Inc.KODBiological Products, (No Diagnostic Substances)$5.8B+556.7%$125.9M10.3 months14.9%40
BioconBIOCON.NSPharmaceutical or biotech (Wikidata)$5.8B−4.5%–––07
Immunovant, Inc.IMVTBiological Products, (No Diagnostic Substances)$5.7B+56.7%$797.8M23.1 months8.4%10
Sumitomo Pharma4506.TPharmaceutical or biotech (Wikidata)$5.5B+2.9%–––16
Mirum PharmaceuticalsMIRMPharmaceutical Preparations$5.3B+11.8%$330.7M23.2 months10.8%55
CG Oncology, Inc.CGONBiological Products, (No Diagnostic Substances)$5.3B+43.9%$19.6M1.5 months11.8%20
Cogent Biosciences, Inc.COGTPharmaceutical Preparations$5.2B+82.8%$181.2M7.6 months11.2%10
Ipca LaboratoriesIPCALAB.NSPharmaceutical or biotech (Wikidata)$5.1B+42.2%–––00
PTC TherapeuticsPTCTPharmaceutical Preparations$5.1B−6.9%$1.0B58 months11.0%33
GrifolsGRFSPharmaceutical Preparations$5.1B−20.7%––1.0%40
Tongrentang600085.SSPharmaceutical or biotech (Wikidata)$5.1B−29.5%–––00
Rongchang Pharmacy Co.,Ltd.9995.HKPharmaceutical or biotech (Wikidata)$5.1B−31.1%–––00
Veradermics, IncMANEPharmaceutical Preparations$5.1B–$319.3M48 months10.2%30
Oruka Therapeutics, Inc.ORKAPharmaceutical Preparations$5.0B+174.3%$268.5M35 months11.7%00
Scholar Rock Holding CorpSRRKBiological Products, (No Diagnostic Substances)$4.9B+45.4%$437.1M17.3 months18.7%00
Baiyunshan600332.SSPharmaceutical or biotech (Wikidata)$4.9B−22.5%–––00
Yuhan000100.KSPharmaceutical or biotech (Wikidata)$4.9B−31.2%–––10
Amarin CorporationAMRNPharmaceutical Preparations$4.8B−41.4%$143.6MCash-generating0.1%01
CRISPR TherapeuticsCRSPBiological Products, (No Diagnostic Substances)$4.8B−27.8%$291.3M8.7 months19.3%00
Travere Therapeutics, Inc.TVTXPharmaceutical Preparations$4.8B+85.0%$117.7MCash-generating13.4%21
Erasca, Inc.ERASPharmaceutical Preparations$4.7B+458.7%$42.5M5.6 months10.1%10
Structure Therapeutics Inc.GPCRPharmaceutical Preparations$4.7B−20.0%$272.6M21.1 months3.5%00
Hikma PharmaceuticalsHIK.LPharmaceutical or biotech (Wikidata)$4.6B−6.2%–––058
Definium TherapeuticsDFTXMedicinal Chemicals & Botanical Products$4.4B+141.9%$655.3M54 months8.4%40
Gossamer Bio, Inc.GOSSPharmaceutical Preparations$4.2B−95.1%$41.1M2.9 months0.3%10
Magenta TherapeuticsDNTHPharmaceutical Preparations$4.2B+109.7%$110.5M10.2 months16.3%00
Rohto Pharmaceutical Co., Ltd.4527.TPharmaceutical or biotech (Wikidata)$4.1B+20.9%–––00
Edgewise Therapeutics, Inc.EWTXPharmaceutical Preparations$4.1B+151.3%$72.3M5.8 months10.3%00
Arcutis Biotherapeutics, Inc.ARQTPharmaceutical Preparations$4.1B+55.6%$34.1MCash-generating17.3%02
CamurusCAMX.STPharmaceutical or biotech (Wikidata)$4.0B−1.9%–––20
Tango Therapeutics (United States)TNGXPharmaceutical Preparations$4.0B+162.9%$345.6M29 months26.4%00
IndiviorINDVPharmaceutical Preparations$4.0B+37.3%$222.0M24 months8.8%07
Adaptive BiotechnologiesADPTBiological Products, (No Diagnostic Substances)$3.8B+47.3%$169.9M75 months7.4%00
Hypera PharmaHYPE3.SAPharmaceutical or biotech (Wikidata)$3.8B+21.5%–––00
Relay TherapeuticsRLAYBiological Products, (No Diagnostic Substances)$3.7B+163.1%$121.2M6.8 months21.3%10
AbCellera Biologics Inc.ABCLPharmaceutical Preparations$3.7B+114.5%$120.1M9.4 months10.6%00
Legend BiotechLEGNPharmaceutical Preparations$3.6B−42.2%$901.9M108 months8.3%00
Organon & Co.OGNPharmaceutical Preparations$3.6B+48.1%$1.1BCash-generating7.2%157
Simcere Pharmaceutical2096.HKPharmaceutical or biotech (Wikidata)$3.5B−15.0%–––00
Telix Pharmaceuticals LimitedTLXPharmaceutical Preparations$3.4B−0.5%$141.9M98 months0.1%52
Xenon PharmaceuticalsXENEPharmaceutical Preparations$3.4B−15.8%$119.5M4.7 months6.2%80
Acadia PharmaceuticalsACADPharmaceutical Preparations$3.4B−6.1%$385.0MCash-generating4.8%34
Ideaya Biosciences (United States)IDYAPharmaceutical Preparations$3.3B+15.6%$272.6M38 months9.5%00
Parabilis Medicines, Inc.PBLSPharmaceutical Preparations$3.1B–$1.1B–6.8%00
Liquidia CorporationLQDAPharmaceutical Preparations$3.1B+52.7%$284.2MCash-generating14.1%00
Tarsus Pharmaceuticals, Inc.TARSBiological Products, (No Diagnostic Substances)$3.1B−4.5%$204.6Mover 10 years13.8%00
Jilin Aodong Medicine000623.SZPharmaceutical or biotech (Wikidata)$3.0B−18.3%–––00
Amylyx PharmaceuticalsAMLXPharmaceutical Preparations$3.0B+81.0%$49.3M4.9 months11.4%11
Disc Medicine, Inc.IRONPharmaceutical Preparations$3.0B−12.9%$98.7M5.9 months18.9%10
Viking TherapeuticsVKTXPharmaceutical Preparations$2.9B−25.1%$125.8M4.4 months22.2%40
Denali Therapeutics Inc.DNLIBiological Products, (No Diagnostic Substances)$2.9B+9.5%$201.5M5.9 months9.7%21
Enliven Therapeutics, Inc.ELVNPharmaceutical Preparations$2.8B+79.0%$135.5M25 months14.1%00
Silence TherapeuticsSLNPharmaceutical Preparations$2.8B+201.2%$72.1M13.2 months1.8%00
Maravai LifeSciences Holdings, Inc.MRVIPharmaceutical Preparations$2.8B+111.2%$70.1M21.3 months3.5%00
Arcus BiosciencesRCUSPharmaceutical Preparations$2.8B+31.5%$150.0M3.7 months10.3%20
Nurix (United States)NRIXPharmaceutical Preparations$2.7B+155.1%$720.2M33 months16.2%00
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited0874.HKPharmaceutical or biotech (Wikidata)$2.7B−26.6%–––00
Beta Pharma Inc.300558.SZPharmaceutical or biotech (Wikidata)$2.7B−28.6%–––00
DBV TechnologiesDBVTBiological Products, (No Diagnostic Substances)$2.7B−47.0%$174.9M13.9 months0.4%30
Neuland LaboratoriesNEULANDLAB.NSPharmaceutical or biotech (Wikidata)$2.6B+21.5%–––00
NeoGenNEOGIn Vitro & In Vivo Diagnostic Substances$2.5B+98.4%$172.0MCash-generating5.4%00
Hutchison China MeditechHCMPharmaceutical Preparations$2.5B−6.2%$71.3M13.2 months0.2%00
MBX Biosciences, Inc.MBXPharmaceutical Preparations$2.5B+297.2%$54.1M8.4 months9.3%10
ADMA Biologics (United States)ADMABiological Products, (No Diagnostic Substances)$2.5B−22.8%$136.0MCash-generating9.2%00
Beam TherapeuticsBEAMBiological Products, (No Diagnostic Substances)$2.5B−7.6%$219.8M7.1 months26.7%00
NewAmsterdam Pharma Co N.V.NAMSPharmaceutical Preparations$2.4B−44.3%$424.2M36 months15.9%30
Bausch HealthBHCPharmaceutical Preparations$2.4B+4.7%$1.8BCash-generating2.2%3116
Prestige BrandsPBHPharmaceutical Preparations$2.4B−19.8%$89.1MCash-generating9.8%00
Precigen, IncPGENPharmaceutical Preparations$2.4B+64.6%$16.3M1.7 months13.3%00
Viridian Therapeutics, Inc.\DEVRDNPharmaceutical Preparations$2.3B−14.4%$165.0M6.5 months15.9%31
Celldex TherapeuticsCLDXIn Vitro & In Vivo Diagnostic Substances$2.3B+10.1%$47.5M2.6 months14.0%40
Supernus Pharmaceuticals, INC.SUPNPharmaceutical Preparations$2.3B−20.7%$180.0MCash-generating8.6%15
Zealand PharmaZEAL.COPharmaceutical Preparations$2.3B−50.9%–––21
Perrigo Company PlcPRGOPharmaceutical Preparations$2.3B−24.6%$399.7MCash-generating17.5%03
Harmony Biosciences Holdings, Inc.HRMYPharmaceutical Preparations$2.2B+46.4%$549.8MCash-generating9.5%00
Aurinia Pharmaceuticals Inc.AUPHPharmaceutical Preparations$2.2B+42.9%$179.7MCash-generating6.0%01
Pharvaris N.V.PHVSPharmaceutical Preparations$2.2B+40.5%––2.7%00
Galena BiopharmaSLSPharmaceutical Preparations$2.1B+396.6%$138.3M59 months27.3%00
Vera Therapeutics, Inc.VERAPharmaceutical Preparations$2.1B−7.0%$48.9M2.0 months23.9%11
VericelVCELBiological Products, (No Diagnostic Substances)$2.1B+14.2%$125.4MCash-generating10.2%20
Agios PharmaceuticalsAGIOPharmaceutical Preparations$2.1B−18.8%$99.6M3.1 months11.8%91
BioCryst PharmaceuticalsBCRXBiological Products, (No Diagnostic Substances)$2.0B+20.4%$155.0MCash-generating10.8%23
CuraleafCURLFMedicinal Chemicals & Botanical Products$2.0B−11.0%$94.6MCash-generating0.3%00
Xeris Biopharma Holdings, Inc.XERSPharmaceutical Preparations$2.0B+19.4%$121.7MCash-generating4.0%02
Galápagos NVLKFTPharmaceutical Preparations$2.0B−13.5%$40.0M–4.9%00
Trulieve Cannabis Corp.TRLVMedicinal Chemicals & Botanical Products$2.0B+33.9%$325.4MCash-generating3.3%00
Recursion PharmaceuticalsRXRXBiological Products, (No Diagnostic Substances)$1.9B−38.0%$545.7M20.4 months29.5%00
Immunome Inc.IMNMPharmaceutical Preparations$1.9B+6.3%$217.7M13.3 months14.8%10
ADARx Pharmaceuticals, Inc.ADRXPharmaceutical Preparations$1.9B–––1.1%20
Sarepta TherapeuticsSRPTPharmaceutical Preparations$1.9B−21.3%$571.1MCash-generating21.6%40
Mineralys Therapeutics, Inc.MLYSPharmaceutical Preparations$1.9B−52.0%$138.3M12.2 months8.8%10
AlvotechALVOBiological Products, (No Diagnostic Substances)$1.9B−41.7%$172.4M41 months1.7%02
ZymeworksZYMEPharmaceutical Preparations$1.8B+38.9%$179.4M29 months7.5%00
Palvella Therapeutics, INC.PVLAPharmaceutical Preparations$1.8B+69.5%$187.8M77 months17.5%20
NovavaxNVAXBiological Products, (No Diagnostic Substances)$1.8B+33.6%$191.5M25 months27.9%00
Zenas BioPharma, Inc.ZBIOPharmaceutical Preparations$1.7B+11.6%$196.6M11.2 months18.3%40
VIR BiotechnologyVIRBiological Products, (No Diagnostic Substances)$1.7B+77.1%$278.7M7.5 months8.9%20
Braveheart Bio, Inc.BRVEPharmaceutical Preparations$1.7B–$122.8M–4.6%10
Xencor IncXNCRPharmaceutical Preparations$1.7B+56.9%$44.7M2.9 months22.0%00
Septerna, Inc.SEPNPharmaceutical Preparations$1.7B+66.2%$84.7MCash-generating6.6%00
Trevi Therapeutics, Inc.TRVIPharmaceutical Preparations$1.7B+15.1%$54.3M14.4 months10.3%20
Biohaven PharmaceuticalsBHVNPharmaceutical Preparations$1.7B−29.5%$238.0M4.8 months12.6%70
Maze Therapeutics, Inc.MAZEBiological Products, (No Diagnostic Substances)$1.7B+9.2%$202.6M20.0 months11.8%00
MesoblastMESOBiological Products, (No Diagnostic Substances)$1.7B−29.4%––2.4%20
UroGen Pharma Ltd.URGNPharmaceutical Preparations$1.7B+101.7%$79.1M5.7 months15.9%32
Ani Pharmaceuticals IncANIPPharmaceutical Preparations$1.7B−23.6%$360.2MCash-generating15.2%024
LBX Pharmacy603883.SSPharmaceutical or biotech (Wikidata)$1.7B−14.3%–––00
Alembic Pharmaceuticals LtdAPLLTD.NSPharmaceutical or biotech (Wikidata)$1.6B−15.8%–––01
Generate Biomedicines, Inc.GENBPharmaceutical Preparations$1.6B–$135.4M–5.8%20
Stoke Therapeutics, Inc.STOKPharmaceutical Preparations$1.6B−25.6%$110.0M9.0 months17.8%10
Intellia TherapeuticsNTLAIn Vitro & In Vivo Diagnostic Substances$1.6B−53.6%$106.1M3.5 months32.2%30
Phibro Animal Health CorpPAHCPharmaceutical Preparations$1.6B−0.9%$61.4MCash-generating2.5%00
Nuvation Bio Inc.NUVBPharmaceutical Preparations$1.6B+30.4%$258.6M25 months16.8%40
ImmunocoreIMCRBiological Products, (No Diagnostic Substances)$1.5B−11.2%$484.9Mover 10 years15.3%21
Ascentage Pharma Group InternationalAAPGPharmaceutical Preparations$1.5B−56.4%––0.0%70
Compass PathwaysCMPSPharmaceutical Preparations$1.5B+68.7%$433.3M33 months12.3%20
Innoviva, Inc.INVAPharmaceutical Preparations$1.5B+22.0%$570.4MCash-generating9.5%00
Natco PharmaNATCOPHARM.NSPharmaceutical or biotech (Wikidata)$1.5B−4.5%–––00
Kailera Therapeutics, Inc.KLRAPharmaceutical Preparations$1.5B–$130.3M–6.7%30
Ultragenyx Pharmaceutical Inc.RAREPharmaceutical Preparations$1.5B−54.2%$125.0M3.0 months20.6%92
Hemab Therapeutics Holdings, Inc.COAGBiological Products, (No Diagnostic Substances)$1.5B–$237.4M–7.3%00
Absci CorpABSICommercial Physical & Biological Research$1.5B+88.5%$107.9M13.3 months21.8%00
SchrödingerSDGRPharmaceutical Preparations$1.5B+20.4%$287.9M23.8 months16.1%00
Pacira BioSciences, Inc.PCRXPharmaceutical Preparations$1.4B+59.0%$205.9MCash-generating20.3%00
Anaptysbio, IncANABPharmaceutical Preparations$1.4B+113.3%$248.5MCash-generating18.0%00
Eton Pharmaceuticals, Inc.ETONPharmaceutical Preparations$1.4B+172.9%$26.8MCash-generating6.4%00
uniQure N.V.QUREPharmaceutical Preparations$1.4B−61.4%$140.0M9.8 months13.8%00
North China Pharmaceutical Group Corp600812.SSPharmaceutical or biotech (Wikidata)$1.4B+4.9%–––00
Rapport Therapeutics, Inc.RAPPPharmaceutical Preparations$1.4B+14.7%$63.6M9.5 months6.7%20
Ocular Therapeutix, IncOCULPharmaceutical Preparations$1.4B−47.2%$598.6M32 months13.4%41
Nanobiotix S.A.NBTXPharmaceutical Preparations$1.3B−16.8%––0.2%00
Inhibrx Biosciences, Inc.INBXBiological Products, (No Diagnostic Substances)$1.3B+139.1%$133.3M12.1 months23.3%10
GH Research PLCGHRSPharmaceutical Preparations$1.3B+35.0%$246.3M68 months2.5%00
Oric Pharmaceuticals, Inc.ORICPharmaceutical Preparations$1.3B−2.1%$37.5M4.1 months15.7%10
First Tracks Biotherapeutics, Inc.TRAXPharmaceutical Preparations$1.3B–$168.0M–14.5%00
Taysha Gene Therapies, Inc.TSHABiological Products, (No Diagnostic Substances)$1.3B−16.2%$455.4M49 months16.9%20
Lb Pharmaceuticals IncLBRXPharmaceutical Preparations$1.3B+155.2%$283.1M67 months18.6%20
Nektar TherapeuticsNKTRPharmaceutical Preparations$1.2B−36.9%$39.3M2.3 months20.4%20
Kardigan, Inc.KARDPharmaceutical Preparations$1.2B–$384.0M–4.8%30
Cronos Group IncCRONMedicinal Chemicals & Botanical Products$1.2B+30.9%$467.0MCash-generating0.9%00
Immatics N.V.IMTXBiological Products, (No Diagnostic Substances)$1.2B−27.8%––2.2%10
Omeros CorpOMERPharmaceutical Preparations$1.2B+104.2%$2.0M0.3 months15.7%01
Opko Health Inc.OPKPharmaceutical Preparations$1.2B+5.3%$300.8M22.1 months4.8%00
Damora Therapeutics, Inc.DMRAPharmaceutical Preparations$1.2B+101.5%$540.5Mover 10 years7.7%00
Syndax Pharmaceuticals IncSNDXPharmaceutical Preparations$1.2B−8.7%$336.5M14.5 months20.4%11
Tyra Biosciences, Inc.TYRAPharmaceutical Preparations$1.1B+32.9%$73.8M8.7 months15.8%00
Bicara Therapeutics Inc.BCAXPharmaceutical Preparations$1.1B−6.1%$96.6M10.0 months16.2%10
Amphastar Pharmaceuticals, Inc.AMPHPharmaceutical Preparations$1.1B+9.3%$223.6MCash-generating10.4%04
Vor Biopharma Inc.VORBiological Products, (No Diagnostic Substances)$1.1B−38.0%$107.9M8.6 months13.2%20
Harrow HealthHROWPharmaceutical Preparations$1.1B−29.7%$83.9MCash-generating20.7%10
Avalyn Pharma Inc.AVLNPharmaceutical Preparations$1.0B–$264.2M–5.7%00
Replimune Group, Inc.REPLBiological Products, (No Diagnostic Substances)$1.0B+144.2%$185.4M8.0 months24.5%20
City Therapeutics, INC.CTYPharmaceutical Preparations$1.0B––––00
KOLON Tissuegene950160.KQPharmaceutical or biotech (Wikidata)$1.0B−67.2%–––10
Janux Therapeutics, Inc.JANXPharmaceutical Preparations$1.0B−38.0%$27.8M4.3 months9.3%00
MannKind CorporationMNKDPharmaceutical Preparations$995.2M−43.4%$52.9MCash-generating8.1%01
Savara IncSVRAPharmaceutical Preparations$965.7M+30.2%$41.8M4.7 months21.2%20
Seaport Therapeutics, Inc.SPTXPharmaceutical Preparations$961.9M–$64.2M–6.8%00
Latigo Biotherapeutics, Inc.LTGOPharmaceutical Preparations$950.4M–$55.0M–1.3%00
CanSino Biologics6185.HKPharmaceutical or biotech (Wikidata)$947.5M−34.0%–––40
Saudi Pharmaceutical Industries and Medical Appliances Corp.2070.SRPharmaceutical or biotech (Wikidata)$914.8M−2.3%–––00
Alto Neuroscience, Inc.ANROPharmaceutical Preparations$907.9M+280.5%$243.7M47 months11.9%00
Monte Rosa TherapeuticsGLUEBiological Products, (No Diagnostic Substances)$906.9M+5.8%$90.1M74 months23.1%00
MeiraGTx Holdings plcMGTXBiological Products, (No Diagnostic Substances)$899.0M+20.8%$143.2MCash-generating6.2%00
Greenland Mines LtdGRMLBiological Products, (No Diagnostic Substances)$888.0M−81.4%$9.3M12.0 months0.6%00
Alumis INC.ALMSPharmaceutical Preparations$881.5M+40.3%$63.7M2.0 months7.4%10
Cullinan OncologyCGEMBiological Products, (No Diagnostic Substances)$880.4M+74.2%$78.6M5.3 months11.9%00
PeptiDream4587.TPharmaceutical or biotech (Wikidata)$879.5M−35.1%–––00
Odyssey Therapeutics, Inc.ODTXBiological Products, (No Diagnostic Substances)$878.3M–$82.0M–6.5%00
Rigel Pharmaceuticals IncRIGLPharmaceutical Preparations$875.3M+67.7%$60.8MCash-generating15.3%14
QuidelQDELIn Vitro & In Vivo Diagnostic Substances$873.7M−54.7%$123.4MCash-generating21.8%00
ArriVent BioPharma, Inc.AVBPPharmaceutical Preparations$872.5M−9.3%$154.7M13.8 months17.1%20
Jade Biosciences, Inc.JBIOPharmaceutical Preparations$862.4M+44.7%$107.2M12.9 months19.1%00
Cryoport, Inc.CYRXPharmaceutical Preparations$862.0M+68.2%$269.3Mover 10 years4.7%00
Inventiva S.A.IVAPharmaceutical Preparations$858.7M−38.8%––2.9%10
MoonLake ImmunotherapeuticsMLTXPharmaceutical Preparations$827.2M+6.6%$477.9M26 months9.5%50
Arbutus BiopharmaABUSPharmaceutical Preparations$825.0M−5.4%$19.2M6.7 months17.2%00
Kura OncologyKURAPharmaceutical Preparations$819.3M−6.4%$70.2M10.8 months16.2%10
Aktis Oncology, Inc.AKTSPharmaceutical Preparations$812.4M–$82.5M–8.8%00
Corvus Pharmaceuticals, Inc.CRVSPharmaceutical Preparations$808.4M+36.5%$18.9M6.5 months21.2%10
Helus Pharma Inc.HELPPharmaceutical Preparations$795.6M+75.5%––4.6%00
Verastem OncologyVSTMPharmaceutical Preparations$794.2M−4.9%$136.4M10.8 months16.5%11
SL Science Holding LtdSLBTBiological Products, (No Diagnostic Substances)$779.5M−85.0%––0.0%00
Ardelyx (United States)ARDXPharmaceutical Preparations$772.5M−38.4%$97.2M32 months11.1%00
Geron CorporationGERNPharmaceutical Preparations$767.8M−0.4%$62.6M6.0 months11.5%21
Collegium Pharmaceutical, IncCOLLPharmaceutical Preparations$763.6M−30.9%$129.5MCash-generating16.9%04
Iambic Therapeutics, Inc.IAMBiological Products, (No Diagnostic Substances)$749.9M––––00
Adlai Nortye Group Ltd.ANLPharmaceutical Preparations$740.6M+585.1%––6.7%00
Obsidian Therapeutics, Inc.OBXPharmaceutical Preparations$727.1M–$0–1.4%00
Apnimed, Inc.APMDPharmaceutical Preparations$716.9M–$172.8M–4.2%10
Lexicon PharmaceuticalsLXRXPharmaceutical Preparations$696.4M+10.2%$40.9M12.7 months5.8%11
Prime Medicine, Inc.PRMEBiological Products, (No Diagnostic Substances)$692.9M−29.9%$47.5M3.6 months17.7%00
Achieve Life Sciences, INC.ACHVIn Vitro & In Vivo Diagnostic Substances$686.9M+58.9%$48.0M12.7 months17.0%10
4D Molecular Therapeutics, Inc.FDMTBiological Products, (No Diagnostic Substances)$686.3M+26.3%$70.4M6.5 months20.4%30
Sana BiotechnologySANABiological Products, (No Diagnostic Substances)$685.5M−54.5%$57.1M5.2 months12.9%00
Chemomab Therapeutics Ltd.CMMBPharmaceutical Preparations$684.7M−64.2%$7.6M8.2 months0.0%00
Gyre Therapeutics, INC.GYREPharmaceutical Preparations$684.7M−26.0%$43.3MCash-generating1.7%00
Pharming Group N.V.PHARPharmaceutical Preparations$683.0M−34.0%$145.3MCash-generating0.0%00
Design Therapeutics, Inc.DSGNPharmaceutical Preparations$680.3M+89.4%$12.9M2.9 months10.6%00
Chong Kun Dang185750.KSPharmaceutical or biotech (Wikidata)$656.9M−18.4%–––20
Aura Investments Ltd.AURABiological Products, (No Diagnostic Substances)$653.3M+11.1%$67.8M8.9 months10.0%00
Ginkgo BioworksDNAPharmaceutical or biotech (Wikidata)$649.2M−23.1%$84.5M6.1 months11.5%00
Attovia Therapeutics, Inc.ATTOBiological Products, (No Diagnostic Substances)$648.2M–$32.8M–3.6%00
Solid Biosciences Inc.SLDBBiological Products, (No Diagnostic Substances)$640.1M+1.5%$159.4M11.1 months11.9%10
Wave Life SciencesWVEPharmaceutical Preparations$625.6M−59.4%$368.0M24.0 months9.4%00
Candel TherapeuticsCADLBiological Products, (No Diagnostic Substances)$622.9M+52.7%$201.6M51 months17.0%20
Olema Pharmaceuticals, Inc.OLMAPharmaceutical Preparations$622.1M−24.0%$48.6M3.9 months16.8%20
Avalo Therapeutics, Inc.AVTXPharmaceutical Preparations$621.0M−24.6%$85.4M17.2 months21.3%00
Nuvectis Pharma, Inc.NVCTPharmaceutical Preparations$608.3M+202.6%$22.2M14.5 months7.7%00
Zevra Therapeutics, INC.ZVRAPharmaceutical Preparations$603.9M−5.9%$145.3MCash-generating12.0%01
Immix Biopharma, Inc.IMMXPharmaceutical Preparations$590.9M+187.8%$225.5M84 months14.5%00
Prokidney Corp.PROKBiological Products, (No Diagnostic Substances)$588.8M−52.9%$74.9M6.8 months5.7%10
Ironwood PharmaceuticalsIRWDPharmaceutical Preparations$582.5M+146.5%$79.1MCash-generating9.4%02
Annexon, Inc.ANNXPharmaceutical Preparations$577.9M+22.8%$199.3M13.1 months21.4%30
CorMedix Inc.CRMDPharmaceutical Preparations$572.5M−27.9%$256.7MCash-generating19.8%11
Phathom Pharmaceuticals, Inc.PHATPharmaceutical Preparations$568.3M−45.8%$182.5M22.5 months12.5%14
Electra Therapeutics, Inc.ETRABiological Products, (No Diagnostic Substances)$564.3M–––1.1%10
Climb Bio, Inc.CLYMPharmaceutical Preparations$564.0M+408.8%$44.1M9.9 months16.9%00
EvotecEVOPharmaceutical Preparations$552.6M−63.5%––0.0%00
Sido MunculSIDO.JKPharmaceutical or biotech (Wikidata)$551.2M−43.3%–––00
Shattuck Labs, Inc.STTKPharmaceutical Preparations$548.0M+201.7%$63.3M18.4 months10.9%00
Bright Minds Biosciences INC.DRUGPharmaceutical Preparations$533.8M−16.9%––8.7%00
Valneva SEVALNBiological Products, (No Diagnostic Substances)$532.0M−45.6%––0.2%00
Puma BiotechnologyPBYIPharmaceutical Preparations$530.7M+87.9%$36.5MCash-generating8.3%00
Medigen Vaccine Biologics6547.TWOPharmaceutical or biotech (Wikidata)$512.4M+43.0%–––10
Eupraxia Pharmaceuticals INC.EPRXPharmaceutical Preparations$508.1M+19.2%$80.6M34 months9.2%00
Faeth Therapeutics, Inc.FTHPharmaceutical Preparations$504.3M+66.8%$26.9M13.4 months8.0%00
CytomX Therapeutics, Inc.CTMXPharmaceutical Preparations$501.1M−28.1%$17.2M2.6 months18.7%00
Entera Bio Ltd.ENTXBiological Products, (No Diagnostic Substances)$497.8M+22.3%$11.3M15.0 months1.4%00
Aclaris Therapeutics, Inc.ACRSPharmaceutical Preparations$497.5M+77.9%$19.2M4.4 months12.4%01
Oculis Holding AGOCSPharmaceutical Preparations$482.2M−65.9%––2.7%00
Neurogene Inc.NGNEPharmaceutical Preparations$478.1M−17.7%$112.5M16.4 months24.9%10
Evolus, Inc.EOLSPharmaceutical Preparations$477.5M+13.0%$45.2M14.8 months8.5%01
REGENXBIO Inc.RGNXBiological Products, (No Diagnostic Substances)$476.3M−38.5%$36.5M1.9 months14.6%30
Monopar TherapeuticsMNPRPharmaceutical Preparations$475.0M−11.7%$52.8M63 months16.2%00
Aquestive Therapeutics, Inc.AQSTPharmaceutical Preparations$471.3M−47.0%$98.5M27 months22.9%04
Vireo Growth Inc.VREOFPharmaceutical Preparations$470.3M−55.7%$122.7MCash-generating0.0%00
Arvinas (United States)ARVNPharmaceutical Preparations$469.8M−24.5%$94.3M4.5 months8.2%00
Crescent Biopharma, INC.CBIOPharmaceutical Preparations$463.2M−0.6%$171.6M30 months12.9%00
National Research CorporationNRCCommercial Physical & Biological Research$457.4M+78.1%$3.3MCash-generating3.1%00
Kamada Ltd.KMDAPharmaceutical Preparations$451.3M+13.2%$75.5MCash-generating0.4%00
TilrayTLRYMedicinal Chemicals & Botanical Products$449.3M−80.5%$215.0M31 months12.7%00
AgomAb Therapeutics NVAGMBBiological Products, (No Diagnostic Substances)$448.2M–––1.9%00
Allogene Therapeutics, Inc.ALLOBiological Products, (No Diagnostic Substances)$442.9M+4.2%$38.6M4.2 months16.1%00
TRex Bio, Inc.TRXBBiological Products, (No Diagnostic Substances)$442.7M––––00
Prothena Corp Public Ltd CoPRTAPharmaceutical Preparations$434.3M−14.7%$288.2M43 months15.6%00
Eikon Therapeutics, Inc.EIKNBiological Products, (No Diagnostic Substances)$434.1M–$142.6M–11.6%20
BlossomHill Therapeutics, Inc.BLSMPharmaceutical Preparations$432.9M–$95.4M–1.5%00
Altimmune, Inc.ALTPharmaceutical Preparations$431.8M−42.0%$63.0M10.6 months23.7%10
DiaMedica Therapeutics Inc.DMACPharmaceutical Preparations$429.2M+21.0%$5.1M2.0 months10.3%10
Ovid Therapeutics Inc.OVIDPharmaceutical Preparations$428.7M+48.3%$11.3M3.2 months9.7%00
Silverback TherapeuticsSPRYPharmaceutical Preparations$426.1M−57.4%$8.2M0.6 months21.3%00
Autolus TherapeuticsAUTLBiological Products, (No Diagnostic Substances)$418.1M−3.0%$171.4M7.5 months3.2%00
Tectonic Therapeutic, Inc.TECXBiological Products, (No Diagnostic Substances)$414.4M+22.8%$227.1M42 months11.4%00
Assembly Biosciences, INC.ASMBPharmaceutical Preparations$409.5M−31.7%$32.3M9.7 months13.9%00
Kyorin Pharmaceutical4569.TPharmaceutical or biotech (Wikidata)$405.5M−22.5%–––00
Myriad GeneticsMYGNIn Vitro & In Vivo Diagnostic Substances$397.4M−46.7%$115.2MCash-generating8.9%00
Capricor Therapeutics, INC.CAPRPharmaceutical Preparations$385.8M+6.2%$20.9M2.7 months32.4%10
Scribe Therapeutics, Inc.SCTXBiological Products, (No Diagnostic Substances)$371.5M–$35.6M–13.0%00
Indaptus Therapeutics, Inc.INDPPharmaceutical Preparations$370.4M−24.9%$7.6M5.4 months0.6%00
CytoDyn Inc.CYDYPharmaceutical Preparations$368.6M−7.1%$16.4M8.7 months2.5%00
Zura Bio LtdZURABiological Products, (No Diagnostic Substances)$365.6M+18.9%$205.1M34 months9.8%00
Alpha Teknova, Inc.TKNOIn Vitro & In Vivo Diagnostic Substances$364.8M+32.5%$6.0M9.1 months3.0%00
Aska Pharmaceutical4886.TPharmaceutical or biotech (Wikidata)$363.4M−3.3%–––00
Fennec Pharmaceuticals INC.FENCBiological Products, (No Diagnostic Substances)$362.1M+25.3%$41.2M86 months1.5%01
MapLight Therapeutics, Inc.MPLTPharmaceutical Preparations$361.5M–$71.6M5.2 months6.9%00
Editas MedicineEDITBiological Products, (No Diagnostic Substances)$360.9M−37.7%$181.8M15.5 months24.2%00
Kyverna Therapeutics, Inc.KYTXBiological Products, (No Diagnostic Substances)$359.0M−12.4%$31.8M2.5 months15.6%10
Rezolute, Inc.RZLTPharmaceutical Preparations$357.4M−57.5%$10.6M2.0 months17.3%00
Galectin Therapeutics IncGALTPharmaceutical Preparations$356.5M−29.2%$13.3M7.9 months9.1%00
C4 Therapeutics (United States)CCCCBiological Products, (No Diagnostic Substances)$354.9M+21.7%$78.6M9.9 months32.8%00
Atea Pharmaceuticals, Inc.AVIRPharmaceutical Preparations$345.7M+40.9%$76.5M6.2 months9.8%20
Prenetics Global LtdPREPharmaceutical Preparations$342.2M+27.9%––2.5%00
Enanta Pharmaceuticals IncENTAPharmaceutical Preparations$337.9M+5.4%$33.4M28 months8.8%00
Relmada Therapeutics, INC.RLMDPharmaceutical Preparations$337.6M+57.5%$11.3M3.2 months12.6%10
Emergent BioSolutionsEBSPharmaceutical Preparations$331.5M−29.4%$139.7MCash-generating18.1%00
Turn Therapeutics Inc.TTRXPharmaceutical Preparations$319.9M+112.2%$9.9M31 months0.9%10
SNDL Inc.SNDLMedicinal Chemicals & Botanical Products$318.7M−45.9%––0.7%00
Impact Biomedical INC.IBOPharmaceutical Preparations$318.1M−60.9%$20.0K0.1 months0.0%00
Opus Genetics, Inc.IRDPharmaceutical Preparations$314.9M+102.4%$88.8M27 months15.6%10
GT Biopharma, Inc.GTBPPharmaceutical Preparations$307.9M+887.7%$5.0M4.5 months0.6%00
Fuji Pharma4554.TPharmaceutical or biotech (Wikidata)$306.3M+15.3%–––00
Canopy Growth CorporationCGCMedicinal Chemicals & Botanical Products$300.3M−45.8%––6.4%00
Benitec Biopharma LtdBNTCPharmaceutical Preparations$296.7M−45.6%$180.0Mover 10 years5.8%00
Arcturus TherapeuticsARCTPharmaceutical Preparations$294.7M−49.8%$191.5M39 months18.9%00
Artiva Biotherapeutics, Inc.ARTVBiological Products, (No Diagnostic Substances)$288.0M−2.0%$301.5M46 months4.7%00
Surrozen, Inc./DESRZNBiological Products, (No Diagnostic Substances)$285.0M+78.6%$102.0M37 months18.6%00
Quoin Pharmaceuticals Ltd.QNRXPharmaceutical Preparations$284.7M−72.8%$3.8M2.9 months0.1%40
Fulcrum Therapeutics (United States)FULCPharmaceutical Preparations$282.3M−58.8%$48.5M9.2 months9.3%00
AgenusAGENBiological Products, (No Diagnostic Substances)$278.5M+59.4%$18.7M2.6 months15.1%00
USANA Health SciencesUSNAMedicinal Chemicals & Botanical Products$274.7M−28.8%$168.6MCash-generating4.2%00
OneMedNet CorpONMDCommercial Physical & Biological Research$273.3M−79.8%$358.0K0.6 months0.2%00
X4 Pharmaceuticals, IncXFORBiological Products, (No Diagnostic Substances)$273.1M−7.2%$195.1M25 months7.7%11
OcugenOCGNBiological Products, (No Diagnostic Substances)$272.2M−49.8%$100.1M20.2 months30.1%30
Cypherpunk Technologies INC.CYPHPharmaceutical Preparations$271.0M+355.6%$7.6M2.8 months12.5%00
Sagimet Biosciences Inc.SGMTPharmaceutical Preparations$270.7M+19.9%$165.9M50 months36.5%10
Prelude Therapeutics IncPRLDPharmaceutical Preparations$268.9M+183.2%$26.3M7.2 months5.7%00
Elite Pharmaceuticals Inc /nv/ELTPPharmaceutical Preparations$267.2M−60.0%$39.4MCash-generating0.2%00
Century Therapeutics (United States)IPSCBiological Products, (No Diagnostic Substances)$267.1M+172.1%$49.6M6.3 months16.1%00
Northwest BiotherapeuticsNWBOPharmaceutical Preparations$264.4M−32.6%$595.0K0.1 months4.5%00
Vicore Pharma Holding ABVCREPharmaceutical Preparations$258.8M–––0.0%00
Aurora CannabisACBMedicinal Chemicals & Botanical Products$257.4M−23.9%––11.9%00
Abeona Therapeutics INC.ABEOPharmaceutical Preparations$253.9M−17.5%$56.2M8.7 months29.5%10
Bicycle Therapeutics (United Kingdom)BCYCPharmaceutical Preparations$253.4M−55.6%$510.1M27 months4.7%00
Pharmaniaga7081.KLPharmaceutical or biotech (Wikidata)$252.3M−40.0%–––00
Standard BioTools Inc.LABPharmaceutical Preparations$250.9M−49.7%$270.0M36 months0.6%00
Kwang Dong Pharmaceutical009290.KSPharmaceutical or biotech (Wikidata)$249.3M+20.9%–––00
Rocket Pharmaceuticals Inc.RCKTPharmaceutical Preparations$247.5M−39.2%$224.5M15.0 months13.7%00
Vanda Pharmaceuticals Inc.VNDAPharmaceutical Preparations$247.0M−22.5%$55.9M5.3 months13.0%96
Cabaletta Bio, Inc.CABABiological Products, (No Diagnostic Substances)$246.7M−49.0%$225.1M18.9 months22.8%20
AC Immune SAACIUPharmaceutical Preparations$246.6M−16.7%––3.5%00
Mereo BioPharma Group plcMREOPharmaceutical Preparations$246.2M−85.0%$30.1M13.4 months0.3%00
Perspective Therapeutics, Inc.CATXPharmaceutical Preparations$246.0M−52.0%$48.5M6.3 months14.5%00
Immuneering CorpIMRXPharmaceutical Preparations$244.2M−35.0%$41.3M10.0 months23.0%10
Lifecore Biomedical, INC. \de\LFCRPharmaceutical Preparations$242.6M−1.2%$17.2Mover 10 years6.5%00
Cresco Labs Inc.CRLBFMedicinal Chemicals & Botanical Products$240.7M−50.8%$57.9MCash-generating0.3%00
Lineage Cell TherapeuticsLCTXBiological Products, (No Diagnostic Substances)$239.7M−42.5%$37.4M20.3 months11.5%00
Vogenx, Inc.VOGXPharmaceutical Preparations$237.8M–$193.0K–0.2%00
SAB Biotherapeutics, Inc.SABSBiological Products, (No Diagnostic Substances)$237.0M+3.8%$8.3M1.9 months4.7%00
Palisade Bio, INC.PALIBiological Products, (No Diagnostic Substances)$232.7M−23.3%$125.2Mover 10 years17.8%00
Q32 Bio Inc.QTTBPharmaceutical Preparations$232.5M+146.4%$106.3M47 months15.7%00
InflaRx N.V.IFRXPharmaceutical Preparations$230.6M+23.3%––7.8%00
BioAge Labs, Inc.BIOAPharmaceutical Preparations$227.0M−4.5%$74.0M10.1 months7.1%00
Siga Technologies IncSIGAPharmaceutical Preparations$226.7M−62.0%$117.6MCash-generating5.0%02
Fate TherapeuticsFATEBiological Products, (No Diagnostic Substances)$225.3M+27.9%$32.4M3.8 months9.0%00
BridgeBio Oncology Therapeutics, Inc.BBOTPharmaceutical Preparations$224.9M−74.8%$54.1M5.0 months4.2%00
Lexeo Therapeutics, Inc.LXEOBiological Products, (No Diagnostic Substances)$221.5M−71.8%$92.8M11.4 months23.5%00
Greenwich LifeSciences, Inc.GLSIPharmaceutical Preparations$220.8M+58.5%$8.9M8.3 months10.8%10
Nature's Sunshine ProductsNATRPharmaceutical Preparations$220.8M−11.5%$82.5MCash-generating4.9%00
Glass House Brands Inc.GLASMedicinal Chemicals & Botanical Products$220.5M−72.2%$23.4MCash-generating0.4%00
Sol-Gel Technologies Ltd.SLGLPharmaceutical Preparations$220.0M+60.1%$11.0MCash-generating4.3%00
Inhibikase Therapeutics, Inc.IKTBiological Products, (No Diagnostic Substances)$219.8M+0.3%$31.2M10.5 months13.9%20
Zafgen (United States)LRMRPharmaceutical Preparations$219.2M−49.8%$92.7M8.5 months14.8%00
Keros Therapeutics, Inc.KROSPharmaceutical Preparations$218.9M−20.2%$257.6M54 months5.8%00
Panacea BiotecPANACEABIO.NSPharmaceutical or biotech (Wikidata)$218.6M−20.2%–––00
OBI Pharma, Inc.4174.TWOPharmaceutical or biotech (Wikidata)$216.8M+6.5%–––10
Alector (United States)ALECBiological Products, (No Diagnostic Substances)$216.1M−36.4%$59.9M4.2 months5.5%00
Lyell Immunopharma, Inc.LYELPharmaceutical Preparations$214.9M−46.9%$73.0M6.5 months5.2%10
Liminatus Pharma, Inc.LIMNBiological Products, (No Diagnostic Substances)$213.6M−94.5%––0.1%00
Macrogenics IncMGNXPharmaceutical Preparations$212.4M+102.1%$113.9M19.5 months11.1%00
Protalix Biotherapeutics IncPLXBiological Products, (No Diagnostic Substances)$205.0M+36.8%$27.4MCash-generating3.8%00
Compugen Ltd.CGENBiological Products, (No Diagnostic Substances)$203.2M+5.8%$90.6MCash-generating2.3%00
Camp4 Therapeutics CorpCAMPPharmaceutical Preparations$199.6M+8.5%$86.4M39 months2.3%00
Niagen Bioscience, Inc.NAGEMedicinal Chemicals & Botanical Products$197.8M−65.9%$66.7MCash-generating4.9%00
ProQR Therapeutics N.V.PRQRPharmaceutical Preparations$196.9M−52.0%––1.9%10
Akebia Therapeutics, Inc.AKBAPharmaceutical Preparations$192.5M−76.3%$155.5MCash-generating8.1%01
Evommune, Inc.EVMNPharmaceutical Preparations$191.5M–$60.0M9.0 months8.0%00
ADC Therapeutics SAADCTPharmaceutical Preparations$188.3M−63.9%$219.1M23.0 months5.4%11
Sutro BiopharmaSTROBiological Products, (No Diagnostic Substances)$187.8M+12.1%$54.3M4.3 months11.1%00
Entrada Therapeutics, Inc.TRDAPharmaceutical Preparations$187.3M−18.1%$99.3M9.0 months7.7%00
Sionna Therapeutics, Inc.SIONPharmaceutical Preparations$184.0M−87.2%$63.3M10.6 months8.4%00
Selecta Biosciences (United States)RNACPharmaceutical Preparations$184.0M−32.5%$147.6M24 months6.1%00
PepGen Inc.PEPGPharmaceutical Preparations$183.9M−45.7%$22.8M3.5 months6.1%00
Alpha Cognition Inc.ACOGBiological Products, (No Diagnostic Substances)$183.5M+23.9%$41.4M16.5 months1.5%01
Invivyd, Inc.IVVDBiological Products, (No Diagnostic Substances)$182.9M−64.3%$160.1M24 months11.5%10
Eledon Pharmaceuticals, Inc.ELDNPharmaceutical Preparations$179.2M−35.9%$6.8M1.2 months9.7%10
Whitehawk Therapeutics, Inc.WHWKPharmaceutical Preparations$174.7M+38.7%$85.2M9.5 months4.8%00
Medicus Pharma Ltd.MDCXPharmaceutical Preparations$170.6M−97.7%$15.2M6.5 months5.8%00
Oramed PharmaceuticalsORMPPharmaceutical Preparations$169.7M+82.9%$15.2M21.4 months3.4%10
Precision BioSciencesDTILBiological Products, (No Diagnostic Substances)$169.1M−11.2%$86.1M17.6 months9.1%00
Adagene Inc.ADAGPharmaceutical Preparations$168.5M+24.4%$74.5M57 months2.7%00
Zentalis Pharmaceuticals, Inc.ZNTLPharmaceutical Preparations$164.1M+53.7%$24.8M2.4 months8.3%00
Nervgen Pharma Corp.NGENPharmaceutical Preparations$163.4M−46.1%––5.6%10
NovaBridge BiosciencesNBPPharmaceutical Preparations$159.5M−77.1%$210.6M–2.7%00
Contineum Therapeutics, Inc.CTNMPharmaceutical Preparations$159.3M−41.1%$14.7M3.1 months13.3%00
MediWound Ltd.MDWDMedicinal Chemicals & Botanical Products$158.8M−34.2%$4.8M3.6 months14.4%11
Anbio BiotechnologyNNNNIn Vitro & In Vivo Diagnostic Substances$158.0M−88.1%$7.8M13.8 months0.1%00
Veraxa Biotech AG - Post de-SPACVRXAPharmaceutical Preparations$157.0M−90.4%––0.2%00
Upstream Bio, Inc.UPBPharmaceutical Preparations$153.9M−86.6%$79.4M6.8 months8.2%00
Korsana Biosciences, Inc.KRSAPharmaceutical Preparations$152.2M+107.3%$1.4M4.7 months0.2%00
Coherus BioSciences (United States)CHRSBiological Products, (No Diagnostic Substances)$151.7M−40.5%$82.9M5.8 months15.1%00
Compass Therapeutics, Inc.CMPXBiological Products, (No Diagnostic Substances)$151.3M−80.3%$35.5M8.0 months22.4%10
Curanex Pharmaceuticals IncCURXPharmaceutical Preparations$150.6M−60.7%$2.9M3.1 months0.0%00
Alx Oncology Holdings IncALXOPharmaceutical Preparations$149.3M−28.0%$22.7M3.5 months4.1%00
Pyxis Oncology, Inc.PYXSPharmaceutical Preparations$146.0M−47.9%$18.9M3.4 months5.9%00
Satellos Bioscience Inc.MSLEPharmaceutical Preparations$145.1M−7.3%$9.8M5.0 months0.5%00
Cardiol Therapeutics Inc.CRDLBiological Products, (No Diagnostic Substances)$144.2M+4.8%––2.3%10
Proteon TherapeuticsTARABiological Products, (No Diagnostic Substances)$140.6M−56.6%$17.1M3.3 months9.8%00
Organigram Global INC.OGIPharmaceutical Preparations$135.5M−48.0%––3.1%00
MaxCyte (United States)MXCTCommercial Physical & Biological Research$134.2M−19.2%$15.0M6.4 months1.1%00
Retension Pharmaceuticals, Inc.RTSNPharmaceutical Preparations$133.5M––––00
KOLON Life Science102940.KQPharmaceutical or biotech (Wikidata)$132.8M−57.9%–––00
Atrium Therapeutics, Inc.RNAPharmaceutical Preparations$132.1M–$72.3M–19.9%00
Tiziana Life Sciences LtdTLSAPharmaceutical Preparations$129.2M−48.2%––2.1%00
Nkarta Therapeutics (United States)NKTXPharmaceutical Preparations$127.9M−22.4%$25.0M3.4 months5.1%00
Korro Bio, Inc.KRROPharmaceutical Preparations$126.9M−79.5%$24.9M4.3 months11.4%00
Organogenesis Holdings Inc.ORGOPharmaceutical Preparations$126.7M−75.6%$46.1MCash-generating11.7%00
Voyager Therapeutics (United States)VYGRBiological Products, (No Diagnostic Substances)$126.6M−58.5%$35.8M3.4 months6.4%00
Acumen Pharmaceuticals, Inc.ABOSBiological Products, (No Diagnostic Substances)$126.6M−13.8%$59.4M6.8 months4.3%00
Outlook Therapeutics, Inc.OTLKBiological Products, (No Diagnostic Substances)$123.7M−61.2%$11.2M2.4 months13.1%11
AN2 Therapeutics, Inc.ANTXPharmaceutical Preparations$123.4M+174.8%$44.3M17.0 months6.6%00
Cue Biopharma, Inc.CUEPharmaceutical Preparations$122.1M−29.6%$17.4M8.5 months9.7%00
Armata Pharmaceuticals, Inc.ARMPBiological Products, (No Diagnostic Substances)$120.8M−4.4%$24.0M12.0 months2.6%00
Semnur Pharmaceuticals, Inc.SMNRPharmaceutical Preparations$119.7M−94.2%$39.0K0.1 months0.0%10
Scienture Holdings, Inc.SCNXPharmaceutical Preparations$119.1M−78.3%$8.2M7.4 months3.2%02
VaxartVXRTBiological Products, (No Diagnostic Substances)$116.8M+33.6%$50.9MCash-generating1.0%00
NRX Pharmaceuticals, Inc.NRXPPharmaceutical Preparations$116.2M−15.6%$26.7M21.5 months22.6%00
Spruce Biosciences, INC.SPRBPharmaceutical Preparations$115.3M−74.6%$96.3M39 months15.0%10
TuHURA Biosciences, Inc./NVHURAPharmaceutical Preparations$112.5M−26.5%$996.0K0.4 months9.6%10
Humacyte, Inc.HUMABiological Products, (No Diagnostic Substances)$112.3M−76.5%$79.9M9.4 months10.6%20
GENELUX CorpGNLXPharmaceutical Preparations$111.5M−56.9%$9.2M4.3 months9.6%00
vTv Therapeutics Inc.VTVTPharmaceutical Preparations$111.5M+33.2%$86.6M100 months3.8%10
Foghorn Therapeutics Inc.FHTXPharmaceutical Preparations$111.3M−53.0%$68.1M9.3 months3.6%00
enGene Therapeutics Inc.ENGNBiological Products, (No Diagnostic Substances)$109.9M−82.5%$41.0M4.8 months2.1%00
Minerva Neurosciences (United States)NERVPharmaceutical Preparations$109.3M−8.1%$24.7M19.9 months5.1%00
Anavex Life Sciences Corp.AVXLBiological Products, (No Diagnostic Substances)$108.0M−87.0%$118.3M42 months14.6%00
Black Diamond Therapeutics, Inc.BDTXBiological Products, (No Diagnostic Substances)$104.3M−54.7%$19.2M6.8 months8.3%00
Inovio PharmaceuticalsINOPharmaceutical Preparations$103.4M−57.5%$31.5M4.5 months20.1%00
LENZ Therapeutics, Inc.LENZBiological Products, (No Diagnostic Substances)$102.0M−91.5%$24.2M3.4 months33.6%01
Jushi Holdings Inc.JUSHMedicinal Chemicals & Botanical Products$101.8M−32.0%$33.3MCash-generating0.4%00
Coya Therapeutics, Inc.COYAPharmaceutical Preparations$100.4M−32.7%$43.2M37 months5.1%10
Tonix PharmaceuticalsTNXPPharmaceutical Preparations$98.3M−69.2%$176.2M16.8 months17.1%01
Unicycive Therapeutics, Inc.UNCYPharmaceutical Preparations$98.2M−25.2%$44.2M18.5 months17.4%00
Cumberland Pharmaceuticals IncCPIXPharmaceutical Preparations$96.9M+88.1%$3.9MCash-generating2.3%02
Immucell Corp /de/ICCCIn Vitro & In Vivo Diagnostic Substances$95.7M+73.9%$8.9MCash-generating0.2%00
Kazia Therapeutics LtdKZIAPharmaceutical Preparations$94.8M+11.8%––9.7%00
Immunic, INC.IMUXPharmaceutical Preparations$94.7M−13.2%$155.1M22.9 months15.2%00
CellectisCLLSBiological Products, (No Diagnostic Substances)$94.7M−77.4%$61.5M18.7 months0.3%00
Polaryx Therapeutics, Inc.PLYXPharmaceutical Preparations$93.2M–$11.5M26 months0.3%00
Atara Biotherapeutics, Inc.ATRABiological Products, (No Diagnostic Substances)$92.7M−37.6%$3.2M1.5 months3.2%00
Insight Molecular Diagnostics Inc.IMDXIn Vitro & In Vivo Diagnostic Substances$92.6M−46.5%$17.8M8.9 months3.0%00
Anixa Biosciences IncANIXPharmaceutical Preparations$92.5M−35.1%$1.4M2.4 months3.9%00
Research Alliance Corp IIIRACCPharmaceutical Preparations$92.2M–$832.8K–0.1%00
Quantum Cyber N.V.QUCYPharmaceutical Preparations$92.1M−26.5%$13.4M16.5 months1.9%00
Neumora Therapeutics, Inc.NMRABiological Products, (No Diagnostic Substances)$88.9M−72.7%$116.8M7.2 months3.6%00
Milestone Pharmaceuticals Inc.MISTPharmaceutical Preparations$88.1M−63.5%$169.7M40 months15.3%01
OnKure Therapeutics, Inc.OKURPharmaceutical Preparations$87.3M−22.5%$166.5M39 months3.0%00
RallybioRLYBPharmaceutical Preparations$86.7M+281.5%$92.8M40 months0.9%00
Rani Therapeutics Holdings, Inc.RANIPharmaceutical Preparations$85.8M−60.0%$4.9M3.4 months5.5%00
Corbus PharmaceuticalsCRBPPharmaceutical Preparations$85.1M−77.2%$23.4M3.8 months15.8%10
Aardvark Therapeutics, Inc.AARDPharmaceutical Preparations$83.8M−70.1%$73.8M14.4 months2.2%00
Taiko Pharmaceutical4574.TPharmaceutical or biotech (Wikidata)$83.8M−10.2%–––00
Tenaya Therapeutics, Inc.TNYABiological Products, (No Diagnostic Substances)$83.7M−79.4%$78.1M14.6 months10.2%00
Ascend Wellness Holdings, Inc.AAWHMedicinal Chemicals & Botanical Products$81.9M−50.8%$67.0MCash-generating0.0%00
Fitlife Brands, INC.FTLFMedicinal Chemicals & Botanical Products$79.4M−52.2%––0.6%00
Pelthos Therapeutics Inc.PTHSBiological Products, (No Diagnostic Substances)$77.3M−30.3%$24.2M8.3 months2.7%00
Zomedica Corp.ZOMDFPharmaceutical Preparations$76.5M+24.0%$7.2M5.3 months0.0%00
Equillium, Inc.EQPharmaceutical Preparations$75.5M−18.5%$57.2M36 months8.7%00
LifeVantageLFVNPharmaceutical Preparations$75.2M−31.9%$14.9MCash-generating8.5%00
ProMIS Neurosciences Inc.PMNPharmaceutical Preparations$73.8M−25.1%$53.4M18.0 months2.7%00
Neonc Technologies Holdings, INC.NTHIPharmaceutical Preparations$72.9M−72.8%$2.0M1.1 months2.9%00
Acrivon Therapeutics, Inc.ACRVPharmaceutical Preparations$72.6M−6.3%$41.4M7.7 months3.8%00
Zhengye Biotechnology Holding LtdZYBTPharmaceutical Preparations$71.6M−45.1%$7.2MCash-generating0.2%00
Telomir Pharmaceuticals, Inc.TELOPharmaceutical Preparations$71.5M−33.8%––1.2%00
Cardiff Oncology, Inc.CRDFBiological Products, (No Diagnostic Substances)$70.0M−58.9%$9.2M2.9 months15.5%00
Medicinova IncMNOVPharmaceutical Preparations$69.9M+15.4%$25.4M32 months0.7%10
Cognition Therapeutics IncCGTXBiological Products, (No Diagnostic Substances)$69.5M−58.0%$34.0M20.2 months8.0%00
PMV Pharmaceuticals, Inc.PMVPPharmaceutical Preparations$68.2M−8.9%$12.5M2.0 months5.2%00
Heron Therapeutics, INC. /de/HRTXPharmaceutical Preparations$66.5M−72.8%$20.7M12.3 months24.2%00
Rafael Holdings, Inc.RFLPharmaceutical Preparations$66.0M−1.5%$30.5M16.1 months1.6%00
Citius Oncology, INC.CTORPharmaceutical Preparations$65.7M−58.4%$16.6M36 months0.3%00
MAIA Biotechnology, Inc.MAIAPharmaceutical Preparations$65.1M−16.4%$00.0 months4.4%10
Lexaria Bioscience Corp.LEXXPharmaceutical Preparations$65.1M−79.0%$3.5M4.8 months1.1%00
Spero Therapeutics, Inc.SPROPharmaceutical Preparations$64.9M−49.5%$50.8MCash-generating1.4%00
Champions OncologyCSBRBiological Products, (No Diagnostic Substances)$64.4M−28.7%$4.4M9.4 months0.5%00
Cingulate Inc.CINGPharmaceutical Preparations$64.1M+19.2%$28.4M17.4 months7.1%00
Oncolytics BiotechONCYPharmaceutical Preparations$64.0M−57.4%$4.1M2.2 months5.8%00
Apollomics Inc.APLMPharmaceutical Preparations$62.9M−39.8%––0.2%00
biote Corp.BTMDMedicinal Chemicals & Botanical Products$61.7M−62.7%$11.2MCash-generating1.9%00
Fortress BiotechFBIOPharmaceutical Preparations$61.6M−31.5%$196.6MCash-generating14.7%00
Biomea Fusion, Inc.BMEAPharmaceutical Preparations$61.6M−43.8%$34.8M7.4 months19.4%00
MindWalkHYFTPharmaceutical Preparations$61.2M−17.1%––1.5%00
XBiotech Inc.XBITPharmaceutical Preparations$61.1M−19.5%$109.5M31 months1.1%00
Verrica Pharmaceuticals Inc.VRCAPharmaceutical Preparations$60.0M−15.9%$11.2M9.5 months1.1%31
Journey Medical CorpDERMPharmaceutical Preparations$59.5M−28.5%$25.6M46 months26.4%09
OS Therapies IncOSTXPharmaceutical Preparations$59.5M−30.3%$205.0K0.2 months5.6%00
Enzon PharmaceuticalsVISKBiological Products, (No Diagnostic Substances)$58.0M+5685.7%$7.9M4.9 months–00
Tenax Therapeutics, INC.TENXPharmaceutical Preparations$56.9M−77.3%$118.0M37 months19.2%30
AcelRx Pharmaceuticals (United States)TLPHPharmaceutical Preparations$56.6M+1.9%$742.0K0.8 months1.4%00
Nomad Power Solutions, INC.NMADPharmaceutical Preparations$56.1M−22.6%––6.3%00
Connect Biopharma Holdings LtdCNTBPharmaceutical Preparations$55.8M−48.8%$27.0M5.7 months5.6%00
Pliant (United States)PLRXPharmaceutical Preparations$55.8M−42.6%$24.9M3.0 months6.9%00
Retrieve Medical Holdings, Inc.RMHIPharmaceutical Preparations$54.9M−43.5%––0.0%00
Xilio Therapeutics, Inc.XLOPharmaceutical Preparations$54.8M−19.9%$136.0M29 months6.2%00
IB Acquisition Corp.IBACCommercial Physical & Biological Research$54.4M+4.1%$30.2K0.2 months0.0%00
Gain Therapeutics, Inc.GANXPharmaceutical Preparations$54.3M−33.4%$13.1M8.1 months7.0%00
Skye Bioscience, Inc.SKYEPharmaceutical Preparations$54.2M−86.1%$8.1M2.3 months0.4%00
PDS Biotechnology CorpPDSBPharmaceutical Preparations$53.9M+4.0%$5.6M2.9 months4.9%00
Yarrow Bioscience, Inc.YARWPharmaceutical Preparations$53.4M+5.8%$22.9M10.7 months7.1%00
Boundless Bio (United States)BOLDPharmaceutical Preparations$52.9M+69.7%$20.2M5.1 months3.4%00
Eloxx Pharmaceuticals, Inc.ELOXBiological Products, (No Diagnostic Substances)$50.4M–$62.0M57 months1.3%00
Werewolf Therapeutics, Inc.HOWLPharmaceutical Preparations$50.3M−35.3%$22.0M5.1 months5.2%00
Caribou Biosciences, Inc.CRBUBiological Products, (No Diagnostic Substances)$49.4M−82.5%$26.2M3.1 months12.0%00
iBio, Inc.IBIOPharmaceutical Preparations$49.1M−10.2%$56.4M29 months6.5%00
LeonaBio, Inc.LONABiological Products, (No Diagnostic Substances)$48.7M+42.8%$32.3M7.5 months0.2%10
Leef Brands Inc.LEEEFMedicinal Chemicals & Botanical Products$48.5M−20.7%$5.0MCash-generating0.2%00
MiNK Therapeutics, Inc.INKTBiological Products, (No Diagnostic Substances)$48.4M−32.3%$8.8M16.7 months1.0%00
Rein Therapeutics, Inc.RNTXPharmaceutical Preparations$48.3M−54.1%$8.5M6.2 months0.8%00
ImageneBio, Inc.IMABiological Products, (No Diagnostic Substances)$46.0M−46.3%$94.7M20.5 months0.3%00
Sangamo Therapeutics, IncSGMOQBiological Products, (No Diagnostic Substances)$45.6M−82.8%$27.6M3.7 months2.2%00
Kalaris Therapeutics, Inc.KLRSBiological Products, (No Diagnostic Substances)$45.5M−58.8%$43.2M12.2 months1.4%00
Tevogen Inc.TVGNBiological Products, (No Diagnostic Substances)$44.8M−80.4%$1.1M1.1 months0.9%00
Serina Therapeutics, Inc.SERPharmaceutical Preparations$42.9M−64.8%$23.0M15.2 months0.2%00
Adicet Bio, Inc.ACETPharmaceutical Preparations$42.6M−71.2%$33.1M4.4 months5.2%00
Clene Inc.CLNNPharmaceutical Preparations$42.5M−61.1%$9.7M6.4 months6.9%00
Inmune Bio, Inc.INMBBiological Products, (No Diagnostic Substances)$42.5M−17.3%$18.4M11.5 months9.6%00
Dogwood Therapeutics, Inc.DWTXPharmaceutical Preparations$42.3M−78.4%$9.6M7.4 months0.1%00
Actinium Pharmaceuticals, Inc.ATNMPharmaceutical Preparations$42.3M−7.9%$36.5M19.1 months2.2%20
Annovis Bio, Inc.ANVSPharmaceutical Preparations$41.8M−50.5%$18.7M8.5 months13.8%30
Aldeyra Therapeutics, Inc.ALDXPharmaceutical Preparations$41.6M−86.9%$45.1M20.8 months5.8%10
Elicio Therapeutics, Inc.ELTXPharmaceutical Preparations$39.9M−83.7%$23.5M7.3 months5.9%00
Instil Bio, Inc.TILBiological Products, (No Diagnostic Substances)$39.7M−69.3%$5.5M2.0 months2.3%00
Veru INC.VERUPharmaceutical Preparations$39.6M−43.5%$23.9M11.5 months8.2%00
Grace Therapeutics, Inc.GRCEPharmaceutical Preparations$39.5M−39.8%$13.8M16.0 months8.2%10
Mustang Bio, INC.MBIOPharmaceutical Preparations$39.5M−75.3%$15.2M37 months0.0%00
Celularity IncCELUPharmaceutical Preparations$38.0M−40.9%$368.0K0.5 months1.2%00
Elutia INC.ELUTBiological Products, (No Diagnostic Substances)$37.6M−8.5%$19.9M5.5 months0.0%00
Adaptimmune (United Kingdom)ADAPYBiological Products, (No Diagnostic Substances)$37.4M−88.2%––0.1%00
Scynexis IncSCYXPharmaceutical Preparations$37.0M−38.4%$10.5M21.3 months6.0%00
Exozymes INC.EXOZBiological Products, (No Diagnostic Substances)$36.3M−69.2%$5.7M9.8 months0.2%00
Lite Strategy, Inc.LITSPharmaceutical Preparations$35.3M−38.3%$5.7M7.5 months0.6%00
CervoMed Inc.CRVOPharmaceutical Preparations$35.2M−67.1%$22.5M9.8 months8.9%00
Incannex Healthcare Inc.IXHLPharmaceutical Preparations$34.7M−73.5%$67.7M63 months3.6%00
CalciMedica, Inc.CALCPharmaceutical Preparations$34.1M−93.8%$18.6M10.6 months0.3%00
Nanoviricides, INC.NNVCPharmaceutical Preparations$33.7M−12.0%$2.8M4.4 months3.6%00
Evaxion A/SEVAXBiological Products, (No Diagnostic Substances)$33.4M−50.7%$23.2M42 months0.5%00
Cell Source, Inc.CLCSPharmaceutical Preparations$33.2M+22.1%––0.0%00
Filana Therapeutics, INC.FLNAPharmaceutical Preparations$33.1M−84.0%$86.6M35 months12.2%00
IRulya Therapeutics Inc.QNCXBiological Products, (No Diagnostic Substances)$32.6M−91.7%$116.0M35 months5.9%00
Charlie's Holdings, Inc.CHUCMedicinal Chemicals & Botanical Products$30.9M−59.0%––0.0%00
Metagenomi Therapeutics, Inc.MGXBiological Products, (No Diagnostic Substances)$30.8M−73.3%$39.0M5.4 months3.4%00
Aligos Therapeutics, Inc.ALGSBiological Products, (No Diagnostic Substances)$30.6M−50.9%$30.4M4.3 months11.4%00
Rockwell Medical Inc.RMTIPharmaceutical Preparations$30.6M−35.1%$10.5MCash-generating1.8%03
BriaCell Therapeutics Corp.BCTXPharmaceutical Preparations$29.7M−71.2%$6.9M2.9 months9.0%10
China Pharma Holdings, INC.CPHIPharmaceutical Preparations$29.4M−62.5%$304.9KCash-generating0.1%00
bioAffinity Technologies, Inc.BIAFCommercial Physical & Biological Research$28.9M−91.9%$2.4M2.7 months1.4%00
Transcode Therapeutics, Inc.RNAZPharmaceutical Preparations$28.8M−88.8%$8.4M4.7 months0.3%00
Cel-Sci (United States)CVMBiological Products, (No Diagnostic Substances)$28.3M−81.8%$6.5M4.6 months3.4%00
BioStem Technologies, Inc.BSEMBiological Products, (No Diagnostic Substances)$28.1M−67.7%$7.0M–0.6%00
Edesa Biotech, Inc.EDSAPharmaceutical Preparations$26.9M+18.0%$10.3M15.7 months2.1%00
Mira Pharmaceuticals, INC.MIRAPharmaceutical Preparations$26.4M−61.2%$3.6M10.2 months1.0%00
IGC Pharma, Inc.IGCPharmaceutical Preparations$26.0M−37.2%$331.0K0.8 months0.9%00
Valion Bio, Inc.VBIOPharmaceutical Preparations$26.0M−98.4%$2.1M2.3 months0.4%00
Natural Alternatives InternationalNAIIMedicinal Chemicals & Botanical Products$25.5M−56.1%$7.4M9.9 months0.0%00
Atossa Therapeutics (United States)ATOSPharmaceutical Preparations$25.3M−82.7%$26.1M9.4 months7.9%00
Zivo Bioscience, Inc.ZIVOBiological Products, (No Diagnostic Substances)$25.3M−48.0%$57.2K0.2 months0.2%00
NextCure, Inc.NXTCPharmaceutical Preparations$25.3M−53.8%$15.3M3.7 months4.7%00
Seres Therapeutics, Inc.MCRBPharmaceutical Preparations$24.5M−87.0%$15.6M4.4 months3.2%00
Earth Science Tech, Inc.ETSTPharmaceutical Preparations$24.4M−47.7%$631.1KCash-generating0.0%00
Abvc Biopharma, INC.ABVCPharmaceutical Preparations$24.4M−68.7%$31.9K0.1 months1.8%00
Matinas BioPharma Holdings, Inc.MTNBPharmaceutical Preparations$23.5M−8.1%$761.0K1.4 months0.4%00
Marimed INC.MRMDMedicinal Chemicals & Botanical Products$23.3M−62.2%$8.4MCash-generating0.0%00
Shuttle Pharmaceuticals Holdings, Inc.SHPHPharmaceutical Preparations$23.2M−86.6%$90.2K0.1 months0.4%00
PMGC Holdings Inc.ELABPharmaceutical Preparations$22.7M−99.8%$18.1M29 months0.3%00
Aytu Biopharma, IncAYTUPharmaceutical Preparations$22.3M−10.5%$26.3MCash-generating3.2%00
Context Therapeutics Inc.CNTXPharmaceutical Preparations$22.0M−83.3%$43.0M15.7 months5.1%00
TherapeuticsMD, Inc.TXMDPharmaceutical Preparations$22.0M+52.0%$9.2M–0.2%00
BeyondSpring Inc.BYSIPharmaceutical Preparations$21.8M−70.1%$2.7M1.7 months5.9%10
Scilex Holding CoSCLXBiological Products, (No Diagnostic Substances)$21.6M−68.0%$566.0K2.1 months2.0%00
Kyntra Bio, INC.KYNBPharmaceutical Preparations$21.1M−49.7%$50.6M28 months2.5%10
Bio Essence CorpBIOEPharmaceutical Preparations$21.0M+449.3%$675Cash-generating–00
Provectus Biopharmaceuticals, INC.PVCTPharmaceutical Preparations$21.0M−33.5%$1.2M5.4 months0.2%00
Akari Therapeutics PlcAKTXPharmaceutical Preparations$21.0M−71.6%$7.7M8.5 months0.6%00
Universe Pharmaceuticals INCUPCPharmaceutical Preparations$20.6M−27.9%$33.6B80 months0.8%00
Optimi Health Corp.OPTHPharmaceutical Preparations$19.9M–––0.5%00
Inhibitor Therapeutics, Inc.INTIPharmaceutical Preparations$19.1M+129.2%$515.8K2.0 months–00
Marker Therapeutics, Inc.MRKRPharmaceutical Preparations$18.7M+9.8%$11.3M17.2 months1.0%00
Cocrystal Pharma, Inc.COCPPharmaceutical Preparations$18.2M−11.7%$7.0M11.1 months0.9%00
Neuphoria Therapeutics Inc.NEUPPharmaceutical Preparations$18.0M−78.5%$19.9M19.3 months0.4%00
Black Hawk Acquisition CorpBKHABiological Products, (No Diagnostic Substances)$17.9M−61.6%$00.0 months0.0%00
aTyr PharmaATYRBiological Products, (No Diagnostic Substances)$16.8M−83.2%$16.2M3.3 months13.1%00
MannatechMTEXMedicinal Chemicals & Botanical Products$16.5M−2.1%$6.0Mover 10 years0.7%00
Quantum Biopharma Ltd.QNTMPharmaceutical Preparations$15.9M−82.3%$1.9M2.8 months5.7%00
Jasper Therapeutics, Inc.JSPRBiological Products, (No Diagnostic Substances)$15.8M−80.6%$7.3M1.3 months18.7%00
TScan Therapeutics, Inc.TCRXBiological Products, (No Diagnostic Substances)$15.0M−91.3%$100.2M9.9 months3.6%10
Actuate Therapeutics, INC.ACTUPharmaceutical Preparations$14.3M−92.0%$4.4M2.7 months5.5%00
ImugeneIMU.AXPharmaceutical or biotech (Wikidata)$14.3M−90.8%–––00
Pasithea Therapeutics Corp.KTTAPharmaceutical Preparations$14.0M−42.6%$45.7M32 months0.5%00
Dyadic International IncDYAIBiological Products, (No Diagnostic Substances)$14.0M−64.0%$1.4M3.0 months0.5%00
BioCardia, Inc.BCDABiological Products, (No Diagnostic Substances)$13.9M−36.6%$4.1M6.6 months4.1%00
Allarity Therapeutics, Inc.ALLRPharmaceutical Preparations$13.8M−39.9%$17.0M12.3 months0.7%00
Kairos Pharma, LTD.KAPAPharmaceutical Preparations$13.6M−93.0%$2.6M8.4 months0.5%00
Tvardi Therapeutics, Inc.TVRDPharmaceutical Preparations$13.3M−84.9%$15.8M8.7 months1.7%00
Adia Med, Inc.ADIAMedicinal Chemicals & Botanical Products$13.2M+288.9%$128.1K7.6 months0.0%00
Vyome Holdings, IncHINDPharmaceutical Preparations$13.0M−64.9%$7.9M19.0 months0.4%00
Vicapsys Life Sciences, Inc.VICPPharmaceutical Preparations$12.9M−77.4%––0.0%00
America Great HealthAAGHPharmaceutical Preparations$12.7M+500.0%$29.3K1.8 months–00
Artelo Biosciences, INC.ARTLPharmaceutical Preparations$12.6M−97.6%$4.2M6.2 months1.0%00
Rocket One Inc.RKTOPharmaceutical Preparations$12.3M−64.8%$7.9M9.4 months4.0%00
Aspire-Lakewood Holdings, Inc.ASBPPharmaceutical Preparations$12.1M−36.5%$12.2M23.5 months1.0%00
Estrella Immunopharma, Inc.ESLABiological Products, (No Diagnostic Substances)$12.1M−84.1%$100.0K0.1 months0.5%00
Lipocine Inc.LPCNPharmaceutical Preparations$12.0M−51.7%$5.0M5.9 months1.2%10
Biofrontera Inc.BFRIPharmaceutical Preparations$11.9M−16.2%$4.7M6.0 months1.0%00
AEON Biopharma, Inc.AEONPharmaceutical Preparations$11.8M−78.5%$3.4M3.4 months4.4%00
Synlogic, INC.SYBXPharmaceutical Preparations$11.8M−47.5%$13.2M48 months0.0%00
Citius Pharmaceuticals, Inc.CTXRPharmaceutical Preparations$11.7M−70.7%$17.0M5.9 months20.4%03
IN8BIO, INC.INABBiological Products, (No Diagnostic Substances)$11.6M−43.3%$18.1M15.0 months0.5%00
Pluri Inc.PLURBiological Products, (No Diagnostic Substances)$11.1M−78.8%$3.5M2.2 months0.2%00
Passage BIO, Inc.PASGBiological Products, (No Diagnostic Substances)$11.1M−57.4%$24.2M9.5 months2.8%00
Cellectar Biosciences, Inc.CLRBPharmaceutical Preparations$10.9M−74.4%$34.0M22.0 months1.8%10
Aspira Women's Health Inc.AWHLIn Vitro & In Vivo Diagnostic Substances$10.7M−54.9%$477.0K1.3 months0.0%00
Dare Bioscience, Inc.DAREPharmaceutical Preparations$10.5M−66.0%$12.6M15.2 months6.0%00
Kiora Pharmaceuticals IncKPRXPharmaceutical Preparations$10.4M−12.9%$7.1M8.2 months0.1%00
Intensity Therapeutics, INC.INTSBiological Products, (No Diagnostic Substances)$10.4M−51.1%$9.5M12.6 months1.2%10
Phio Pharmaceuticals Corp.PHIOPharmaceutical Preparations$10.2M−58.4%$13.0M14.6 months0.8%00
Ensysce BiosciencesENSCPharmaceutical Preparations$10.1M−78.2%$676.7K0.8 months5.6%10
Palatin Technologies IncPTNPharmaceutical Preparations$10.1M−19.7%$7.5M6.6 months20.5%00
BullFrog AI Holdings, Inc.BFRGPharmaceutical Preparations$10.0M−63.3%$6.9M15.3 months4.0%00
Biovie INC.BIVIPharmaceutical Preparations$10.0M−30.8%$9.0M5.7 months11.0%00
Tempest Therapeutics, Inc.TPSTPharmaceutical Preparations$9.7M−94.0%$779.0K0.4 months3.8%10
Adial Pharmaceuticals, INC.ADILPharmaceutical Preparations$9.6M−59.3%$28.7M53 months7.0%00
Theriva Biologics, Inc.TOVXPharmaceutical Preparations$9.4M−51.0%$11.3M9.5 months3.7%00
Hepion Pharmaceuticals, Inc.HEPAPharmaceutical Preparations$9.2M+43.8%$1.6M12.4 months0.0%00
Vistagen Therapeutics, Inc.VTGNPharmaceutical Preparations$9.0M−95.0%$17.0M3.3 months8.5%20
Caladrius BiosciencesLSTAPharmaceutical Preparations$8.8M−59.8%$10.4M9.2 months0.4%00
Brainstorm Cell Therapeutics INC.BCLIBiological Products, (No Diagnostic Substances)$8.6M+19.2%$22.0K0.0 months0.3%10
Oncotelic Therapeutics, Inc.OTLCPharmaceutical Preparations$8.5M−81.5%$409.0K3.1 months0.0%10
Lantern Pharma Inc.LTRNPharmaceutical Preparations$8.4M−83.5%$6.7M5.3 months3.8%00
Biomerica IncBMRAIn Vitro & In Vivo Diagnostic Substances$8.3M−39.8%$2.7M8.3 months0.6%00
MetaVia Inc.MTVAPharmaceutical Preparations$8.1M−88.5%$12.6M10.0 months1.8%00
Bolt Biotherapeutics, Inc.BOLTPharmaceutical Preparations$8.1M−27.0%$12.9M4.5 months1.3%00
Karyopharm Therapeutics Inc.KPTIPharmaceutical Preparations$7.9M−94.1%$55.0M11.2 months26.7%30
ZIOPHARM OncologyTCRTPharmaceutical Preparations$7.8M+0.3%$124.0K0.5 months0.4%00
Soligenix, INC.SNGXPharmaceutical Preparations$7.5M−79.2%$9.8M10.9 months0.8%00
InMed Pharmaceuticals Inc.INMPharmaceutical Preparations$7.5M−35.2%$2.2M3.0 months0.6%00
Zeo ScientifiX, Inc.ZEOXBiological Products, (No Diagnostic Substances)$7.4M−52.5%$1.8M17.7 months0.0%00
Aprea Therapeutics, Inc.APREPharmaceutical Preparations$7.1M−64.0%$41.2M41 months4.0%00
CNS Pharmaceuticals, Inc.CNSPPharmaceutical Preparations$7.1M−47.3%$20.0M15.8 months0.1%00
Exicure, INC.XCURPharmaceutical Preparations$7.0M−76.4%$1.7M2.5 months0.6%00
Senti Biosciences Holdings, Inc.SNTIBiological Products, (No Diagnostic Substances)$6.9M−89.7%$6.5M2.1 months1.6%00
Alzamend Neuro, Inc.ALZNPharmaceutical Preparations$6.4M−40.1%$7.6M13.3 months2.3%00
FibroBiologics, Inc.FBLGPharmaceutical Preparations$6.4M−88.0%$3.5M2.7 months7.8%00
Enveric Biosciences, Inc.ENVBPharmaceutical Preparations$6.3M−84.6%––0.3%00
Acurx Pharmaceuticals, Inc.ACXPPharmaceutical Preparations$6.0M−83.3%$10.7M20.8 months2.1%00
Reviva Pharmaceuticals Holdings, INC.RVPHPharmaceutical Preparations$5.9M−96.1%$19.9M11.8 months3.1%10
Traws Pharma, Inc.TRAWPharmaceutical Preparations$5.9M−86.7%$5.0M3.9 months4.5%00
HST Global, Inc.HSTCPharmaceutical Preparations$5.7M+66750.0%–––00
Integrated Biopharma IncINBPPharmaceutical Preparations$5.6M−41.9%$4.5MCash-generating0.0%00
Imunon, Inc.IMNNPharmaceutical Preparations$5.6M−80.5%$6.9M5.5 months3.1%10
LianBioLIANYPharmaceutical Preparations$5.5M−15.0%––0.0%00
Apimeds Pharmaceuticals US, Inc.APUSPharmaceutical Preparations$5.3M−81.1%$278.4K0.3 months5.3%00
Cyanotech CorpCYANMedicinal Chemicals & Botanical Products$5.2M+141.4%$649.0K4.4 months–00
Pulmatrix, Inc.PULMPharmaceutical Preparations$5.2M−70.7%$2.2M5.6 months1.3%00
AIM ImmunoTech Inc.AIMBiological Products, (No Diagnostic Substances)$5.1M−93.2%$9.9M10.5 months4.6%00
Cardio Diagnostics Holdings, Inc.CDIOIn Vitro & In Vivo Diagnostic Substances$5.0M−60.8%$00.0 months0.0%00
NeuroSense Therapeutics Ltd.NRSNPharmaceutical Preparations$4.9M−89.1%$166.0K0.3 months1.4%00
Processa Pharmaceuticals, Inc.PCSAPharmaceutical Preparations$4.8M−77.4%$196.3K0.2 months0.1%00
Creative Medical Technology Holdings, INC.CELZBiological Products, (No Diagnostic Substances)$4.8M−79.8%$8.7M18.7 months2.5%00
Gelteq LtdGELSPharmaceutical Preparations$4.7M−62.8%––5.0%00
Longeveron Inc.LGVNPharmaceutical Preparations$4.7M−82.0%$10.1M6.6 months3.2%00
Jaguar Health, Inc.JAGXPharmaceutical Preparations$4.4M−99.7%$3.8M6.0 months5.6%00
Xenetic Biosciences (United States)XBIOPharmaceutical Preparations$4.4M−55.3%$6.5M43 months0.5%00
Azitra, Inc.AZTRPharmaceutical Preparations$4.4M−89.8%$6.7M7.6 months0.4%00
RedHill Biopharma Ltd.RDHLPharmaceutical Preparations$4.2M−66.7%––2.5%00
Q/c Technologies, INC.QCLSIn Vitro & In Vivo Diagnostic Substances$4.1M−88.5%$307.6K0.4 months11.6%00
Emmaus Life Sciences, Inc.EMMAPharmaceutical Preparations$4.1M+386.7%$2.8M53 months0.0%02
EnlivexENLVPharmaceutical Preparations$4.1M−98.8%$1.9M2.2 months0.5%00
NuCana plcNCNAPharmaceutical Preparations$4.0M−80.5%––2.5%00
Cadrenal Therapeutics, Inc.CVKDPharmaceutical Preparations$3.9M−92.0%$2.4M2.6 months3.0%00
Kala Pharmaceuticals (United States)KALAPharmaceutical Preparations$3.9M−99.7%$229.0K0.1 months7.0%00
PharmaCyte Biotech, Inc.PMCBBiological Products, (No Diagnostic Substances)$3.7M−64.3%$17.7M54 months1.2%00
Polomar Health Services, Inc.PMHSPharmaceutical Preparations$3.5M−37.5%$87.8K3.3 months–00
Ctt Pharmaceutical Holdings, INC.CTTHPharmaceutical Preparations$3.5M−29.3%$31–0.0%00
Dermata Therapeutics, Inc.DRMAPharmaceutical Preparations$3.5M−78.0%$4.4M6.3 months2.1%00
CV Sciences, Inc.CVSIPharmaceutical Preparations$3.4M−62.5%$266.0K14.2 months0.0%00
GRI Bio, Inc.GRIPharmaceutical Preparations$3.2M−97.3%$10.9M10.8 months3.2%00
Ernexa Therapeutics Inc.ERNAPharmaceutical Preparations$3.1M−93.7%$5.0M8.4 months1.2%00
Clearmind Medicine Inc.CMNDPharmaceutical Preparations$3.1M−99.8%$3.9M9.9 months3.0%00
60 Degrees Pharmaceuticals, INC.SXTPPharmaceutical Preparations$3.0M−85.8%$1.0M1.5 months3.8%01
Aptevo Therapeutics Inc.APVOPharmaceutical Preparations$2.9M−94.3%$9.8M4.4 months6.6%00
Weed, INC.BUDZCommercial Physical & Biological Research$2.8M−52.5%$1.1K0.1 months0.1%00
Akanda Corp.AKANMedicinal Chemicals & Botanical Products$2.7M−97.9%––1.7%00
Bioxytran, IncBIXTPharmaceutical Preparations$2.7M−66.1%––0.0%00
Lunai Bioworks Inc.LNAIPharmaceutical Preparations$2.5M−94.9%$1.7M3.9 months2.9%00
Aibotics, INC.AIBTMedicinal Chemicals & Botanical Products$2.5M−21.6%$233.4K6.0 months0.3%00
HCW Biologics Inc.HCWBPharmaceutical Preparations$2.4M−94.5%$741.3K0.8 months3.3%00
VivoSim Labs, INC.VIVSBiological Products, (No Diagnostic Substances)$2.4M−93.7%$1.7M2.0 months4.8%00
Accustem Sciences Inc.ACUTPharmaceutical Preparations$2.4M−85.5%––0.0%00
iSpecimen Inc.ISPCCommercial Physical & Biological Research$2.4M−96.8%$4.4M8.1 months6.4%00
Volitionrx LtdVNRXIn Vitro & In Vivo Diagnostic Substances$2.3M−98.1%$2.8M1.6 months8.8%00
International Stem Cell CORPISCOPharmaceutical Preparations$2.3M+93.3%$1.1Mover 10 years0.0%00
Procyon CorpPCYNPharmaceutical Preparations$2.2M+119.5%–––00
Jupiter Neurosciences, INC.JUNSPharmaceutical Preparations$2.2M−97.6%––4.6%00
Abpro Holdings, Inc.ABPOBiological Products, (No Diagnostic Substances)$2.1M−93.7%$4.2M7.7 months0.3%00
IM Cannabis Corp.IMCCMedicinal Chemicals & Botanical Products$2.1M−97.5%––5.5%00
BioAtlaBCABBiological Products, (No Diagnostic Substances)$2.0M−97.1%$1.5M0.5 months4.5%00
Propanc Biopharma, Inc.PPCBPharmaceutical Preparations$2.0M−99.2%––1.1%00
Vaccinex, INC.VCNXPharmaceutical Preparations$2.0M+57.3%––0.1%00
Calidi Biotherapeutics, Inc.CLDIBiological Products, (No Diagnostic Substances)$2.0M−97.0%$4.3M2.8 months9.0%00
Oragenics IncOGENPharmaceutical Preparations$1.9M−66.3%$3.9M5.0 months18.7%00
Silo Pharma, Inc.SILOPharmaceutical Preparations$1.8M−86.3%$3.3M10.2 months2.2%00
Virax Biolabs Group LtdVRAXIn Vitro & In Vivo Diagnostic Substances$1.8M−90.9%––0.5%00
XORTX Therapeutics Inc.XRTXPharmaceutical Preparations$1.8M−81.5%––3.5%00
Genprex, Inc.GNPXPharmaceutical Preparations$1.7M−99.5%$15.2M12.7 months11.8%00
GeoVax Labs, Inc.GOVXPharmaceutical Preparations$1.7M−98.3%$3.1M2.0 months3.8%00
Onconetix, Inc.ONCOPharmaceutical Preparations$1.7M−99.7%$5.9M7.3 months12.4%00
Lftd Partners INC.LIFDPharmaceutical Preparations$1.5M−60.0%$1.5MCash-generating0.0%00
Avenue Therapeutics, INC.ATXIPharmaceutical Preparations$1.4M−41.9%$1.9M21.5 months0.0%00
Protagenic Therapeutics, Inc.\newPTIXPharmaceutical Preparations$1.4M−76.3%$566.0K3.4 months0.7%00
Lakewood-Amedex Biotherapeutics Inc.LABTPharmaceutical Preparations$1.4M–$2.6M–5.5%00
Panacea Life Sciences Holdings, INC.PLSHMedicinal Chemicals & Botanical Products$1.2M−5.7%–––00
Axim Biotechnologies, INC.AXIMPharmaceutical Preparations$996.5K−52.9%––0.0%00
Sunshine Biopharma Inc.SBFMPharmaceutical Preparations$930.6K−98.8%$13.7M29 months3.4%00
Nexentis Technologies Inc.NXTSPharmaceutical Preparations$916.0K−97.7%$7.6M20.7 months2.6%00
Evofem Biosciences, Inc.EVFMPharmaceutical Preparations$888.0K−33.0%$285.0K13.6 months0.0%02
Biodexa Pharmaceuticals PlcBDRXPharmaceutical Preparations$887.0K−99.0%––0.8%00
Skinvisible, INC.SKVIPharmaceutical Preparations$843.0K−71.6%$4.0K6.3 months–00
Silexion Therapeutics CorpSLXNBiological Products, (No Diagnostic Substances)$801.8K−99.6%$2.2M2.2 months88.6%00
Curis IncCRISBiological Products, (No Diagnostic Substances)$794.0K−98.8%$5.1M2.1 months8.6%00
BioXcel Therapeutics, Inc.BTAIQPharmaceutical Preparations$782.6K−98.9%$12.8M2.7 months6.3%00
Decoy Therapeutics Inc.DCOYPharmaceutical Preparations$769.8K−97.6%$8.3M15.2 months22.9%00
SciSparcSPRCPharmaceutical Preparations$761.1K−95.7%––2.2%00
China SXT Pharmaceuticals, Inc.SXTCPharmaceutical Preparations$739.5K−100.0%$28.2M84 months0.6%00
Nutra Pharma CorpNPHCMedicinal Chemicals & Botanical Products$716.0K0.0%$12.2K0.1 months–00
Target Group Inc.CBDYMedicinal Chemicals & Botanical Products$431.9K−56.2%$14.0K0.5 months0.0%00
Cero Therapeutics Holdings, INC.CEROBiological Products, (No Diagnostic Substances)$429.8K−99.7%$862.8K0.6 months0.0%00
ZyVersa Therapeutics, Inc.ZVSAPharmaceutical Preparations$388.6K−64.4%$302.7K0.9 months1.7%00
Bioadaptives, INC.BDPTPharmaceutical Preparations$354.5K−93.3%$29.2K0.7 months–00
CNBX Pharmaceuticals Inc.CNBXPharmaceutical Preparations$321.2K−60.0%$9.5K0.6 months0.0%00
Neutra Corp.NTRRMedicinal Chemicals & Botanical Products$291.8K−50.0%–––00
Functional Brands Inc.MEHAMedicinal Chemicals & Botanical Products$285.7K–$352.1K2.3 months0.5%00
Foxo Technologies INC.FOXOCommercial Physical & Biological Research$182.4K−96.2%$58.4K0.2 months0.4%00
Regen BioPharma IncRGBPPharmaceutical Preparations$167.5K−99.2%$2390.0 months0.0%00
CDT Equity Inc.CDTPharmaceutical Preparations$141.6K−100.0%$747.0K0.7 months4.9%00
Ocean Biomedical, Inc.OCEAPharmaceutical Preparations$139.4K−80.0%––0.0%00
ProPhase LabsPRPHPharmaceutical Preparations$138.8K−99.8%$20.0K0.0 months0.5%00
Synergy CHC Corp.SNYRQMedicinal Chemicals & Botanical Products$119.2K−99.7%$292.1K0.9 months4.5%00
Petros Pharmaceuticals, Inc.PTPIPharmaceutical Preparations$114.4K−88.3%$3.5M7.1 months0.1%00
ProtoKinetix, Inc.PKTXPharmaceutical Preparations$82.3K−96.2%$1.1K0.1 months–00
Anebulo Pharmaceuticals, Inc.ANEBPharmaceutical Preparations$40.8K−100.0%$9.0M18.3 months1.0%00
One World Products, Inc.OWPCPharmaceutical Preparations$36.0K−98.2%–––00
Windtree Therapeutics Inc /de/WINTBiological Products, (No Diagnostic Substances)$33.7K−99.2%$204.0K0.2 months0.0%00
Bio-Path Holdings, INC.BPTHPharmaceutical Preparations$15.1K−99.6%$12.0K0.0 months0.0%00
Aditxt, Inc.ADTXPharmaceutical Preparations$816−100.0%$268.9K0.2 months–00
Trevena IncTRVNPharmaceutical Preparations$432−95.8%––0.4%01
Keenova Therapeutics plcPharmaceutical Preparations––$963.7MCash-generating–00
Catalyst PharmaceuticalsCPRXPharmaceutical Preparations––$755.9MCash-generating–04
Dyne Therapeutics, Inc.DYNPharmaceutical Preparations––$676.1M18.3 months–20
Terns Pharmaceuticals, Inc.Pharmaceutical Preparations––$524.7M77 months–00
Sinovac BiotechSVAPharmaceutical Preparations––$488.2M11.4 months–150
Metsera, Inc.Pharmaceutical Preparations––$448.5M54 months–00
Apellis Pharmaceuticals, Inc.Pharmaceutical Preparations––$405.2MCash-generating–22
Avidity Biosciences, Inc.Pharmaceutical Preparations––$382.5M7.1 months–30
Merus N.V.Pharmaceutical Preparations––$367.5M23.7 months–00
Cidara TherapeuticsCDTXBiological Products, (No Diagnostic Substances)––$293.7M20.0 months–10
Theravance Biopharma, Inc.TBPHPharmaceutical Preparations––$219.8MCash-generating–11
Amicus TherapeuticsFOLDPharmaceutical Preparations––$214.0MCash-generating–43
KalVista Pharmaceuticals, Inc.Pharmaceutical Preparations––$213.8M16.8 months–00
Day One Biopharmaceuticals, Inc.Pharmaceutical Preparations––$197.1M22.8 months–10
Akero Therapeutics, Inc.Pharmaceutical Preparations––$176.0M9.2 months–30
AtaiBeckley Inc.Pharmaceutical Preparations––$168.8M19.1 months–00
Dynavax Technologies CorpPharmaceutical Preparations––$160.2MCash-generating–00
Nuvalent, Inc.Pharmaceutical Preparations––$159.7M6.1 months–00
Esperion TherapeuticsESPRPharmaceutical Preparations––$156.2M103 months–00
Soleno Therapeutics IncPharmaceutical Preparations––$133.0MCash-generating–00
Apogee Therapeutics, Inc.Biological Products, (No Diagnostic Substances)––$105.6M5.4 months–00
Catabasis PharmaceuticalsCATBPharmaceutical Preparations––$96.3M14.2 months–00
XOMA Royalty CorpPharmaceutical Preparations––$85.6MCash-generating–00
Arcellx, Inc.Biological Products, (No Diagnostic Substances)––$80.3M4.6 months–00
Avadel PharmaceuticalsAVDLPharmaceutical Preparations––$79.8M20.4 months–00
Repare Therapeutics Inc.Pharmaceutical Preparations––$72.8M11.4 months–00
Kezar Life Sciences, Inc.Pharmaceutical Preparations––$66.2M18.9 months–00
Centessa Pharmaceuticals plcPharmaceutical Preparations––$62.4M3.6 months–10
Barinthus Biotherapeutics plc.Pharmaceutical Preparations––$59.3M19.5 months–00
Mural Oncology plcPharmaceutical Preparations––$58.9M5.5 months–00
Mersana Therapeutics (United States)Pharmaceutical Preparations––$56.4M8.2 months–00
Crinetics PharmaceuticalsPharmaceutical Preparations––$55.5M1.6 months–30
LAVA Therapeutics NVPharmaceutical Preparations––$49.7M30 months–00
Forte Biosciences, Inc.Pharmaceutical Preparations––$49.6M10.0 months–00
RAPT Therapeutics, Inc.Pharmaceutical Preparations––$37.9M5.5 months–00
Assertio Holdings, Inc.Pharmaceutical Preparations––$33.7M57 months–00
Ventyx Biosciences, Inc.Pharmaceutical Preparations––$32.0M2.9 months–00
IO Biotech, Inc.Pharmaceutical Preparations––$30.7M4.5 months–10
Atai Beckley N.V.Pharmaceutical Preparations––$30.4M4.4 months–00
Avalanche BiotechnologiesADVMBiological Products, (No Diagnostic Substances)––$26.1M3.4 months–00
OmniAb, Inc.OABIWCommercial Physical & Biological Research––$24.3M11.5 months–00
Bioharvest Sciences INC.BHSTPharmaceutical Preparations–−83.5%$23.0M38 months–00
Generation Bio Co.Pharmaceutical Preparations––$21.9M3.0 months–00
Inotiv, Inc.Commercial Physical & Biological Research––$15.2M16.0 months–00
Regencell BioscienceRGCMedicinal Chemicals & Botanical Products–−42.3%$14.2M22.1 months–00
Applied Therapeutics, Inc.Pharmaceutical Preparations––$11.9M1.7 months–10
Evoke Pharma IncPharmaceutical Preparations––$11.6M25 months–00
Revelation Biosciences, INC.REVBPharmaceutical Preparations––$11.5M15.9 months–00
Iterum Therapeutics plcPharmaceutical Preparations––$11.0M4.9 months–01
Lomond Therapeutics Holdings, Inc.Pharmaceutical Preparations––$10.9M4.9 months–00
Ionetix Corp / DE /In Vitro & In Vivo Diagnostic Substances––$10.9M––00
BGM Group Ltd.BGMPharmaceutical Preparations–−97.1%$9.8M50 months–00
Kitov PharmaPPBTPharmaceutical Preparations–−81.8%$8.7M18.5 months–00
Moleculin Biotech, Inc.MBRXPharmaceutical Preparations––$7.3M3.6 months–10
Clearside Biomedical, Inc.Pharmaceutical Preparations––$6.8M3.3 months–00
CQENS Technologies Inc.Pharmaceutical Preparations––$6.7M19.5 months–00
Bon Natural Life LtdBONMedicinal Chemicals & Botanical Products–−44.6%$6.3MCash-generating–00
Vitro Biopharma, Inc.Biological Products, (No Diagnostic Substances)––$5.7M21.4 months–00
CASI Pharmaceuticals, Inc.CASIFPharmaceutical Preparations–−94.2%$5.6M3.3 months–00
Can Fite BiopharmaCANFPharmaceutical Preparations–−81.9%$5.5M7.4 months–20
Galera Therapeutics, Inc.Pharmaceutical Preparations––$5.5M14.1 months–00
Sonnet BioTherapeutics Holdings, Inc.Pharmaceutical Preparations––$5.1M4.8 months–00
OKYO Pharma LtdOKYOBiological Products, (No Diagnostic Substances)–−37.5%$4.6M30 months–10
Galmed Pharmaceuticals Ltd.EOCNPharmaceutical Preparations–−74.4%$4.0M7.6 months–00
Bioline Rx Ltd.BLRXPharmaceutical Preparations–−46.9%$3.2M4.8 months–00
PRF Technologies Ltd.PRFXPharmaceutical Preparations–−88.2%$3.1M9.5 months–00
Carisma Therapeutics Inc.Pharmaceutical Preparations––$2.8M0.6 months–00
NewcelX Ltd.NCELPharmaceutical Preparations–−84.0%$2.2M9.5 months–00
Lipella Pharmaceuticals INC.LIPOPharmaceutical Preparations–−99.9%$1.9M5.6 months–00
Scinai Immunotherapeutics Ltd.SCNIBiological Products, (No Diagnostic Substances)–−94.8%$1.7M3.3 months–00
CytoMed Therapeutics LtdGDTCPharmaceutical Preparations–−62.9%$1.6M6.8 months–00
Nasus Pharma LtdNSRXPharmaceutical Preparations–−59.0%$1.2M3.0 months–10
Jyong Biotech Ltd.MENSPharmaceutical Preparations–−96.8%$1.2M4.6 months–00
Aptose Biosciences Inc.Biological Products, (No Diagnostic Substances)––$935.0K0.4 months–00
Revium Rx.RVRCPharmaceutical Preparations–+175.0%$842.0K––00
Adaptin Bio, INC.APTNBiological Products, (No Diagnostic Substances)––$670.5K2.6 months–00
Heat BiologicsHTBXPharmaceutical Preparations––$581.6K0.3 months–00
Healthy Extracts INC.HYEXMedicinal Chemicals & Botanical Products–−18.6%$190.0KCash-generating–00
Kaya Holdings, Inc.Pharmaceutical Preparations––$26.1K0.4 months–00
Bespoke Extracts, Inc.BSPKPharmaceutical Preparations–−99.8%$16.7K0.7 months–00
China Foods Holdings Ltd.CFOOMedicinal Chemicals & Botanical Products–+58.2%$15.9K0.6 months–00
Vitaspring Biomedical CO. LTD.VSBCCommercial Physical & Biological Research–−96.8%$13.4KCash-generating–00
Regenerex Pharma, INC.Pharmaceutical Preparations––$11.7K0.1 months–00
Voyager Acquisition Corp./Cayman IslandsBiological Products, (No Diagnostic Substances)––$6.1KCash-generating–00
BioKey (Cayman), Inc.Pharmaceutical Preparations––$4.6K––00
REST EZ Inc.Pharmaceutical Preparations––$3.9KCash-generating–00
TFA Therapeutics, Inc.RAJAFMedicinal Chemicals & Botanical Products–0.0%$3.2K1.1 months–00
Nika Pharmaceuticals, IncNIKAPharmaceutical Preparations–−14.4%$2.9K0.4 months–00
Burzynski Research Institute IncIn Vitro & In Vivo Diagnostic Substances––$2.2K0.1 months–00
Raphael Pharmaceutical Inc.RAPHMedicinal Chemicals & Botanical Products–+277.5%$1.0K0.3 months–00
Fuss Brands Corp.Pharmaceutical Preparations––$6330.0 months–00
Cannapharmarx, INC.CPMDPharmaceutical Preparations–−58.3%$5550.0 months–00
Trafalgar International, INC.GCANPharmaceutical Preparations––$1110.0 months–00
Cannabis Bioscience International Holdings, Inc.CBIHCommercial Physical & Biological Research–−60.0%$900.0 months–00
Cannaisseur Group Inc.TCRGMedicinal Chemicals & Botanical Products––$410.0 months–00
Agentix Corp.AGTXBiological Products, (No Diagnostic Substances)–−59.9%$380.0 months–00
Mosaic ImmunoEngineering Inc.CPMVBiological Products, (No Diagnostic Substances)–−19.2%$260.0 months–00
ARIAD PharmaceuticalsARIABiological Products, (No Diagnostic Substances)–––––00
Trinity Biotech PLCTRIBIn Vitro & In Vivo Diagnostic Substances–−72.4%–––00
Gelstat CorpGSACPharmaceutical Preparations–−25.0%–––00
Nymox Pharmaceutical CorpNYMXFIn Vitro & In Vivo Diagnostic Substances–−56.2%–––00
XTL BioXTLBPharmaceutical Preparations–−61.1%–––00
Biomolecular Life Holdings, INC.BIOMPharmaceutical Preparations–−19.0%–––00
Alterity Therapeutics LtdATHEPharmaceutical Preparations–−48.2%–––00
Medicure IncMCUJFPharmaceutical Preparations–+297.4%–––13
GlobeImmuneGBIMPharmaceutical Preparations–0.0%–––00
Anthera PharmaceuticalsANTHPharmaceutical Preparations–0.0%–––00
Avricore Health Inc.AVCRFPharmaceutical Preparations–−97.7%–––00
Complete GenomicsGNOMCommercial Physical & Biological Research–+53.3%–––00
Green Planet Bio Engineering Co. Ltd.GPLBBiological Products, (No Diagnostic Substances)–−78.0%$00.0 months–00
Curative Biotechnology IncCUBTBiological Products, (No Diagnostic Substances)–−24.2%–––00
Glucose Health, Inc.GLUCMedicinal Chemicals & Botanical Products–+1156.9%–––00
BetterLife Pharma Inc.BETRFPharmaceutical Preparations–+308.7%–––00
ImmutepIMMPPharmaceutical Preparations–+51.7%–––00
Addex Therapeutics Ltd.ADXNPharmaceutical Preparations–−73.3%–––00
Innate Pharma SAIPHABiological Products, (No Diagnostic Substances)–−31.4%–––01
Altamira Therapeutics Ltd.CYTOFPharmaceutical Preparations–+12.5%–––00
Grey Matters Health Inc.AGNPFPharmaceutical Preparations–−47.4%–––00
Immuron LtdIMRNPharmaceutical Preparations–−57.3%–––00
Bonus Biogroup Ltd.BONS.TABiological Products, (No Diagnostic Substances)–−24.9%–––00
PyroGenesis Canada Inc.PYRGFPharmaceutical Preparations–−4.9%–––00
Molecular PartnersMOLNBiological Products, (No Diagnostic Substances)–−6.6%–––00
CBD Life Sciences Inc.CBDLMedicinal Chemicals & Botanical Products–−50.0%–––00
PureTech VenturesPTCHFPharmaceutical Preparations–−11.9%–––00
Medicenna Therapeutics Corp.MDNAFPharmaceutical Preparations–−53.5%–––00
Opthea LimitedCKDXFBiological Products, (No Diagnostic Substances)–−97.7%–––00
Genenta Science S.p.A.GNTABiological Products, (No Diagnostic Substances)–−79.6%–––00
Beroni Group LtdBNIGFPharmaceutical Preparations–0.0%–––00
MindMaze Therapeutics Holding SAMMTZFPharmaceutical Preparations–−94.4%–––00
Intercure Ltd.INCRPharmaceutical Preparations–−40.6%–––00
INNOCAN PHARMA CorpINNPFPharmaceutical Preparations–−89.4%–––00
Adastra Holdings Ltd.XTXXFPharmaceutical Preparations–−98.6%–––00
Radiopharm Theranostics LtdRADXPharmaceutical Preparations–−85.5%–––00
Asep Medical Holdings Inc.SEPSFIn Vitro & In Vivo Diagnostic Substances–−97.2%–––00
Psyence Biomedical LTD.PBMPharmaceutical Preparations–−97.0%–––00
Beacon Topco, INC.CLYDPharmaceutical Preparations––$0––00
Eagle PharmaceuticalsEGRXPharmaceutical or biotech (Wikidata)–−41.0%–––00
OrexoORXOFPharmaceutical or biotech (Wikidata)–−73.1%–––00
Guilin Sanjin Pharmaceutical Company Limited002275.SZPharmaceutical or biotech (Wikidata)–−19.2%–––00
Neptunus Biology000078.SZPharmaceutical or biotech (Wikidata)–−45.8%–––00
IpsenIPSEYPharmaceutical or biotech (Wikidata)–+24.2%–––106
Wakamoto Pharmaceutical4512.TPharmaceutical or biotech (Wikidata)–+5.9%–––00
Morishita Jintan4524.TPharmaceutical or biotech (Wikidata)–+3.2%–––00
Nan Liu Enterprise Company Limited6504.TWPharmaceutical or biotech (Wikidata)–−16.9%–––00
NKGen Biotech Inc. (United States)NKGNPharmaceutical or biotech (Wikidata)–0.0%–––00
Il-Yang Pharmaceutical (South Korea)007570.KSPharmaceutical or biotech (Wikidata)–−44.1%–––00
NurExone Biologic Inc.J90.FPharmaceutical or biotech (Wikidata)–−35.7%–––00
Mayinglong Pharmaceutical Group600993.SSPharmaceutical or biotech (Wikidata)–−15.3%–––00
Sartorius AGSRT3.FPharmaceutical or biotech (Wikidata)–+13.0%–––00
BeiersdorfBDRFFPharmaceutical or biotech (Wikidata)–−11.6%–––00
Prescient TherapeuticsPTX.AXPharmaceutical or biotech (Wikidata)–+30.9%–––00
Rafa Laboratories, Ltd.RAFA.TAPharmaceutical or biotech (Wikidata)–––––02
BiohitBIOBV.HEPharmaceutical or biotech (Wikidata)–−28.1%–––00
Biotie TherapiesBITIPharmaceutical or biotech (Wikidata)–−8.3%–––00
CK Life Sciences0775.HKPharmaceutical or biotech (Wikidata)–−44.6%–––00
Global Bio-Chem0809.HKPharmaceutical or biotech (Wikidata)–−54.4%–––00
Lijun International Pharmaceutical (Holding) Co. Ltd.2005.HKPharmaceutical or biotech (Wikidata)–−5.2%–––00
DermapharmDMP.FPharmaceutical or biotech (Wikidata)–+16.2%–––00
UCBUCBJFPharmaceutical or biotech (Wikidata)–−20.9%–––1830
Tempo Scan PacificTSPC.JKPharmaceutical or biotech (Wikidata)–−8.2%–––00

Companies: SEC industry codes 2833 to 2836 and 8731 from SEC EDGAR, plus companies outside the SEC whose Wikidata industry is pharmaceuticals or biotechnology. Runway on cash as described above. Short % from FINRA as of Sep 30, 2026. Also: active phase 3 trials (recruiting, active or not yet recruiting) from ClinicalTrials.gov; original NDA and BLA approvals on file at Drugs@FDA.